2024-03-28T13:03:10.13Z
https://stacks.cdc.gov/fedora/oai
oai:cdc.stacks:cdc:39717
2017-02-01T21:29:06Z
For parents: a positive Zika virus test : what does it mean for my child?eng2 unnumbered pagescdc:39717http://stacks.cdc.gov/view/cdc/39717/ChildrenParentsZika Virus Infection/DiagnosisYou’ve just learned from your pediatrician or healthcare provider that your child has a positive Zika test result, which means your childhas a Zika virus infection. During the first week of infection, Zika virus is in a person’s blood. Prevent your child from getting bitten by mosquitoes. While the virus is in your child’s blood, a mosquito can bite the child, get infected with the Zika virus, and spread the virus to other people.Everyone who has Zika should take steps to protect themselves and others. This fact sheet explains what to do.CS266324-Atestresults-children-fs.pdfIs Zika a more serious illness for children than it is for adults? -- Will a Zika infection affect my child’s growth and development, or his or her reproductive health? -- How can I treat my child’s symptoms of Zika? -- How can I prevent my child from spreading Zika to others? -- Is my child protected from future infections?Centers for Disease Control and Prevention (U.S.). Emergency Operations Center. Joint Information Center.
oai:cdc.stacks:cdc:38357
2017-02-02T14:16:25Z
A New Automated Method and Sample Data Flow for Analysis of Volatile Nitrosamines in Human Urine*Am J Analyt ChemAm J Analyt Chem. 7(2):165-178.cdc:38357http://stacks.cdc.gov/view/cdc/38357/ArticleVolatile NitrosaminesAutomationSample Data FlowGas ChromatographyTandem Mass SpectrometryVolatile nitrosamines (VNAs) are a group of compounds classified as probable (group 2A) and possible (group 2B) carcinogens in humans. Along with certain foods and contaminated drinking water, VNAs are detected at high levels in tobacco products and in both mainstream and sidestream smoke. Our laboratory monitors six urinary VNAs-N-nitrosodimethylamine (NDMA), N-nitrosomethylethylamine (NMEA), N-nitrosodiethylamine (NDEA), N-nitrosopiperidine (NPIP), N-nitrosopyrrolidine (NPYR), and N-nitrosomorpholine (NMOR)-using isotope dilution GC-MS/MS (QQQ) for large population studies such as the National Health and Nutrition Examination Survey (NHANES). In this paper, we report for the first time a new automated sample preparation method to more efficiently quantitate these VNAs. Automation is done using Hamilton STAR(â„¢) and Caliper Staccato(â„¢) workstations. This new automated method reduces sample preparation time from 4 hours to 2.5 hours while maintaining precision (inter-run CV < 10%) and accuracy (85% - 111%). More importantly this method increases sample throughput while maintaining a low limit of detection (<10 pg/mL) for all analytes. A streamlined sample data flow was created in parallel to the automated method, in which samples can be tracked from receiving to final LIMs output with minimal human intervention, further minimizing human error in the sample preparation process. This new automated method and the sample data flow are currently applied in bio-monitoring of VNAs in the US non-institutionalized population NHANES 2013-2014 cycle.CC999999/Intramural CDC HHS/United States2017-02-01T00:00:00Z26949569PMC4770837Hodgson, James A.Seyler, Tiffany H.McGahee, ErnestArnstein, StephenWang, Lanqing
oai:cdc.stacks:cdc:41210
2017-02-02T20:18:21Z
Postpartum teens' perception of the food environments at home and schoolHealth Educ BehavHealth Educ Behav. 43(1):76-85.cdc:41210http://stacks.cdc.gov/view/cdc/41210/ArticleAdolescentAdolescent HealthBeveragesCross-Sectional StudiesDietEnergy IntakeEnvironmentFemaleFoodFood ServicesHealth BehaviorHumansLongitudinal StudiesObesityPostpartum PeriodSchoolsSurveys and QuestionnairesBackgroundAn environment that supports healthy eating is one factor to prevent obesity. However, little is known about postpartum teen's perceptions of their home and school environments and how this relates to dietary behaviors.PurposeThis study explores the relationship between home and school environments and dietary behaviors for postpartum teens.DesignConducted cross-sectionally during 2007-2009 across 27 states; included 889 postpartum teens enrolled in Parents as Teachers Teen Program. Data included measures of sociodemographics and perceptions of school and home food environments. A 7-day recall of snack and beverage frequency assessed dietary behaviors. Logistic regression explored associations between baseline environment measures and dietary behaviors at baseline and post-intervention (approximately 5 months after baseline) for the control group.ResultsRespondents reported greater access and selection (i.e., variety of choices) of healthy foods and beverages at home than school. At baseline, fruit and vegetable intake was associated with home selection (1.9, 95% CI: 1.3-2.9) and availability (1.8, 95% CI: 1.3-2.6), sweet snack consumption was associated with selection (1.5, 95% CI: 1.0-2.1), and total snack consumption and sugar-sweetened beverage intake were associated with selection (snack: 2.1, 95% CI: 1.5-3.0; beverage: 1.7, 95% CI: 1.2-2.4) and availability (snack: 2.1, 95% CI: 1.4-3.1; beverage: 1.5, 95% CI: 1.0-2.3). Water intake at baseline and at the post-intervention for control group teens was associated with selection (1.6, 95% CI: 1.1-2.2). No significant associations were identified between the school environment and dietary behaviors.ConclusionsInterventions should target improvements in the home environment for high risk, postpartum teens.P30 DK092950/DK/NIDDK NIH HHS/United States1 R01 CA121534/CA/NCI NIH HHS/United StatesT32CA009314-3/CA/NCI NIH HHS/United StatesU48/DP001903/DP/NCCDPHP CDC HHS/United States1P30DK092950/DK/NIDDK NIH HHS/United StatesR01 CA121534/CA/NCI NIH HHS/United StatesT32 CA009314/CA/NCI NIH HHS/United States2017-02-01T00:00:00Z26272783PMC5015643Tabak, Rachel G.Joshu, Corinne E.Clarke, Megan A.Schwarz, Cynthia D.Haire-Joshu, Debra L.
oai:cdc.stacks:cdc:39048
2017-02-02T20:18:26Z
An international survey of cerebral palsy registers and surveillance systemsDev Med Child NeurolDev Med Child Neurol. 58(Suppl 2):11-17.cdc:39048http://stacks.cdc.gov/view/cdc/39048/ArticleCerebral PalsyData CollectionHumansInternational CooperationPopulation SurveillancePrevalenceRegistriesAIMTo describe cerebral palsy (CP) surveillance programmes and identify similarities and differences in governance and funding, aims and scope, definition, inclusion/exclusion criteria, ascertainment and data collection, to enhance the potential for research collaboration.METHODRepresentatives from 38 CP surveillance programmes were invited to participate in an online survey and submit their data collection forms. Descriptive statistics were used to summarize information submitted.RESULTSTwenty-seven surveillance programmes participated (25 functioning registers, two closed owing to lack of funding). Their aims spanned five domains: resource for CP research, surveillance, aetiology/prevention, service planning, and information provision (in descending order of frequency). Published definitions guided decision making for the definition of CP and case eligibility for most programmes. Consent, case identification, and data collection methods varied widely. Ten key data items were collected by all programmes and a further seven by at least 80% of programmes. All programmes reported an interest in research collaboration.INTERPRETATIONDespite variability in methodologies, similarities exist across programmes in terms of their aims, definitions, and data collected. These findings will facilitate harmonization of data and collaborative research efforts, which are so necessary on account of the heterogeneity and relatively low prevalence of CP.CC999999/Intramural CDC HHS/United States2017-02-01T00:00:00Z26781543PMC4837944Goldsmith, ShonaMcIntyre, SarahSmithers-Sheedy, HayleyBlair, EveCans, ChristineWatson, LindaYeargin-Allsopp, Marshalyn
oai:cdc.stacks:cdc:41193
2017-02-02T20:18:27Z
Comparison of employer productivity metrics to lost productivity estimated by commonly used questionnairesJ Occup Environ MedJ Occup Environ Med. 58(2):170-177.cdc:41193http://stacks.cdc.gov/view/cdc/41193/ArticleAbsenteeismAdultCross-Sectional StudiesEfficiencyFemaleHealth SurveysHumansMaleMiddle AgedOccupational HealthReproducibility of ResultsSelf ReportSurveys and QuestionnairesObjectiveTo assess construct and discriminant validity of four health-related work productivity loss questionnaires in relation to employer productivity metrics, and to describe variation in economic estimates of productivity loss provided by the questionnaires in healthy workers.Methods58 billing office workers completed surveys including health information and four productivity loss questionnaires. Employer productivity metrics and work hours were also obtained.ResultsProductivity loss questionnaires were weakly to moderately correlated with employer productivity metrics. Workers with more health complaints reported greater health-related productivity loss than healthier workers, but showed no loss on employer productivity metrics. Economic estimates of productivity loss showed wide variation among questionnaires, yet no loss of actual productivity.ConclusionsAdditional studies are needed comparing questionnaires with objective measures in larger samples and other industries, to improve measurement methods for health-related productivity loss.T42OH008491/OH/NIOSH CDC HHS/United StatesR01 OH008017/OH/NIOSH CDC HHS/United StatesT42 OH008491/OH/NIOSH CDC HHS/United StatesUL1 TR000448/TR/NCATS NIH HHS/United StatesR01OH008017/OH/NIOSH CDC HHS/United States2017-02-01T00:00:00Z26849261PMC5009902Gardner, Bethany T.Dale, Ann MarieBuckner-Petty, SkyeVan Dillen, LindaAmick, Benjamin C.Evanoff, Bradley
oai:cdc.stacks:cdc:42099
2017-02-02T20:18:27Z
Effects of a Workplace Intervention on Parent-Child RelationshipsJ Child Fam StudJ Child Fam Stud. 25(2):553-561.cdc:42099http://stacks.cdc.gov/view/cdc/42099/ArticleParent-adolescent relationshipsParental employmentWork and FamilyWorkplace InterventionRandomized TrialThis study tested whether effects of a workplace intervention, aimed at promoting employees' schedule control and supervisor support for personal and family life, had implications for parent-adolescent relationships; we also tested whether parent-child relationships differed as a function of how many intervention program sessions participants attended. Data came from a group randomized trial of a workplace intervention, delivered in the information technology division of a Fortune 500 company. Analyses focused on 125 parent-adolescent dyads that completed baseline and 12-month follow-up home interviews. Results revealed no main effects of the intervention, but children of employees who attended 75% or more program sessions reported more time with their parent and more parent education involvement compared to adolescents whose parents attended less than 75% of sessions, and they tended to report more time with parent and more parental solicitation of information about their experiences compared to adolescents whose parents were randomly assigned to the usual practice condition.U01 HD051217/HD/NICHD NIH HHS/United StatesU01 HD051256/HD/NICHD NIH HHS/United StatesU01 OH008788/OH/NIOSH CDC HHS/United StatesU01 AG027669/AG/NIA NIH HHS/United StatesU01 HD059773/HD/NICHD NIH HHS/United StatesU01 HD051276/HD/NICHD NIH HHS/United StatesU01 HD051218/HD/NICHD NIH HHS/United States2017-02-01T00:00:00Z26957897PMC4779369McHale, Susan M.Davis, Kelly D.Green, KaylinCasper, LynneKan, Marni L.Kelly, Erin L.King, Rosalind BerkowitzOkechukwu, Cassandra
oai:cdc.stacks:cdc:43228
2017-02-02T20:18:28Z
Effects of titanium dioxide nanoparticles on human keratinocytesDrug Chem ToxicolDrug Chem Toxicol. 40(1):90-100.cdc:43228http://stacks.cdc.gov/view/cdc/43228/ArticleTitanium dioxidenanoparticlesapoptosiskeratinocytesreactive oxygen speciesTitanium dioxide (TiO2) is a ubiquitous whitening compound widely used in topical products such as sunscreens, lotions and facial creams. The damaging health effects of TiO2 inhalation has been widely studied in rats, mice and humans showing oxidative stress increase, DNA damage, cell death and inflammatory gene upregulation in lung and throat cells; however, the effects on skin cells from long-term topical use of various products remain largely unknown. In this study, we assessed the effect of specific TiO2 nanoparticles (H2TiO7) on a human keratinocyte cell line (HaCaT). We performed a comparative analysis using three TiO2 particles varying in size (Fine, Ultrafine and H2TiO7) and analyzed their effects on HaCaTs. There is a clear dose-dependent increase in superoxide production, caspase 8 and 9 activity, and apoptosis in HaCaTs after treatment with all three forms of TiO2; however, there is no consistent effect on cell viability and proliferation with either of these TiO2 particles. While there is data suggesting UV exposure can enhance the carcinogenic effects of TiO2, we did not observe any significant effect of UV-C exposure combined with TiO2 treatment on HaCaTs. Furthermore, TiO2-treated cells showed minimal effects on VEGF upregulation and Wnt signaling pathway thereby showing no potential effect on angiogenesis and malignant transformation. Overall, we report here an increase in apoptosis, which may be caspase 8/Fas-dependent, and that the H2TiO7 nanoparticles, despite their smaller particle size, had no significant enhanced effect on HaCaT cells as compared to Fine and Ultrafine forms of TiO2.CC999999/Intramural CDC HHS/United StatesSC1 CA173069/CA/NCI NIH HHS/United StatesSC1 HL112630/HL/NHLBI NIH HHS/United States2017-02-01T00:00:00Z27310834PMC5161738Wright, ClaytonIyer, Anand Krishnan V.Wang, LiyingWu, NianqiangYakisich, Juan S.Rojanasakul, YonAzad, Neelam
oai:cdc.stacks:cdc:44016
2017-02-02T20:24:30Z
Enhanced HER2 Degradation in Breast Cancer Cells by Lysosome-Targeting Gold NanoconstructsACS NanoACS Nano. 9(10):9859-9867.cdc:44016http://stacks.cdc.gov/view/cdc/44016/Articlenanoparticlestargeted drug deliverygold nanostarsDNA aptamerslysosomesAptamers, NucleotideBase SequenceBreastBreast NeoplasmsCell Line, TumorCell SurvivalDrug CarriersDrug Delivery SystemsFemaleGoldHumansLysosomesNanostructuresProteolysisReceptor, ErbB-2This paper describes how gold nanoparticle nanoconstructs can enhance anticancer effects of lysosomal targeting aptamers in breast cancer cells. Nanoconstructs consisting of anti-HER2 aptamer (human epidermal growth factor receptor 2, HApt) densely grafted on gold nanostars (AuNS) first targeted HER2 and then were internalized via HER2-mediated endocytosis. As incubation time increased, the nanoconstruct complexes were found in vesicular structures, starting from early endosomes to lysosomes as visualized by confocal fluorescence and differential interference contrast microscopy. Within the target organelle, lysosomes, HER2 was degraded by enzymes at low pH, which resulted in apoptosis. At specific time points related to the doubling time of the cancer cells, we found that accumulation of HER2-HApt-AuNS complexes in lysosomes, lysosomal activity, and lysosomal degradation of HER2 were positively correlated. Increased HER2 degradation by HApt-AuNS triggered cell death and cell cycle arrest in the G0/G1 phase inhibition of cell proliferation. This work shows how a perceived disadvantage of nanoparticle-based therapeutics-the inability of nanoconstructs to escape from vesicles and thus induce a biological response-can be overcome by both targeting lysosomes and exploiting lysosomal degradation of the biomarkers.DP1 EB016540/EB/NIBIB NIH HHS/United StatesU54 CA151880/CA/NCI NIH HHS/United StatesDP1EB016540/DP/NCCDPHP CDC HHS/United StatesT32 AR060710/AR/NIAMS NIH HHS/United States2017-01-30T00:00:00Z26335372PMC5279887Lee, HyojinDam, Duncan Hieu M.Ha, Ji WonYue, JunOdom, Teri W.
oai:cdc.stacks:cdc:25728
2017-02-03T12:31:59Z
Sequence for donning personal protective equipment (PPE) = Secuencia para ponerse el equipo de protección personal (PPE) ; Sequence for removing personal protective equipment (PPE) = Secuencia para quitarse el equipo de protección personal (PPE)Secuencia para ponerse el equipo de protección personal (PPE)Secuencia para quitarse el equipo de protección personal (PPE)Sequence for donning personal protective equipment (PPE) [Spanish]Sequence for removing personal protective equipment (PPE)Sequence for removing personal protective equipment (PPE) [Spanish]engspa2 unnumbered pageshttp://stacks.cdc.gov/view/cdc/25728/Cross Infection/prevention & controlDisease Transmission, Infectious/prevention & controlHealth PersonnelHospitalsProtective ClothingProtective DevicesRespiratory Protective DevicesProcedures originally written for the Severe acute respiratory syndrome (SARS) outbreak in 2004. Original date: 4/28/04; modified 3/23/11.In English and Spanish.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:11363
2017-02-03T14:35:27Z
Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and HealthWorking together for safety: a state team approach to preventing occupational injuries in young peopleengv, 43 p. : ill. ; 28 cm.printTexthttp://stacks.cdc.gov/view/cdc/11363/Industrial accidentsTeenagers--EmploymentIndustrial safetyOccupational diseases--PreventionOccupational HealthSafetyHD7262 .E38 2005"Most young people work at some time during high school. Although working can be a positive experience, it also has risks. The Institute of Medicine's Committee on the Health and Safety Implications of Child Labor reports that 50 percent of youths between ages 15 and 17 work at some time during the course of a year and that 80 percent of students work at least some time during high school. Every year, at least 100,000 of these young people seek treatment in an emergency room for a work-related injury. Every year, at least 70 young people are killed on the job. Young people are injured in the workplace at twice the rate of adult workers. Yet no single agency has the ultimate responsibility for protecting young people from workplace hazards. What is needed is an approach that brings coherence and coordination to this mission. A State team for young worker safety is a coalition of agencies and organizations whose goal is to protect the safety and health of young people in the workplace. The American Heritage Dictionary defines a team as "a group organized to work together." This definition goes to the heart of the State team approach. A State team is not a committee, task force, or blue ribbon panel. State teams do not exist to make recommendations, issue reports, share information, or discuss issues - although they can do all of these. State teams exist to work on concrete projects that protect young people from injuries in the workplace. Over the past 5 years, several of the States in the Northeastern part of the United States have successfully used the State team approach to improve their capacity to protect young workers." - NIOSHTIC-2prepared by Education Development Center, Inc., prepared for the National Institute for Occupational Safety and Health."CDC workplace Safety and Health."--Cover."May 2005"--P. ii.Also available via the World Wide Web on PDF.Education Development CenterNational Institute for Occupational Safety and Health
oai:cdc.stacks:cdc:44010
2017-02-03T19:57:20Z
Key messages – Zika Virus Disease : updated February 1, 2017eng41 numbered pagescdc:44010http://stacks.cdc.gov/view/cdc/44010/Disease OutbreaksHealth CommunicationZika VirusZika Virus InfectionFOR EXTERNAL USE 2/1/17Purpose: This document is for internal and external use. The document contains cleared key messages for use in developing other materials.Updated information is in blue.Background on Zika -- Outbreak Summary -- Symptoms -- Transmission: Mosquito (Vector) Transmisssion; Periconceptional/Intrauterine/Perinatal transmission; Sexual Transmission; Blood Transfusion; Breastfeeding -- Testing & Diagnosis -- Treatment -- Prevention: Preventing Mosquito Transmission: Insect Repellent, Controlling Mosquitoes at Home, Modified Mosquitoes, Aerial Spraying; Preventing Sexual transmission; Preventing Zika Infection in Pregnancy: Recommendations for Couples Interested in Conceiving; Preventing Unintended Pregnancy during the Zika Virus Outbreak; Zika Virus Blood Screening, Puerto Rico Survey of Blood Collection Centers -- Health Effects Associated with Zika: Microcephaly, Diagnosis of Microcephaly, Pyriproxyfen -- Guillain-BarreÌ? Syndrome -- Zika & the United States: Zika Pregnancy Registries, National Reporting: Pregnant Women & outcomes -- Zika & US Territories -- Zika & Colombia -- Travel Recommendations: International and Overseas US Territory Travel Notices; Travel to Southeast Asia; Domestic Travel Guidance (applies to continental United States and Hawaii), Travel to Florida -- CDC Guidance & Recommendations for Healthcare Providers: Obstetrical Healthcare Providers: Amniocentesis; Prenatal Diagnosis of Microcephaly; Pediatric Healthcare Providers: Birth Defects, Potential Outcomes & Prognosis, Clinical Guidance; Infection Control -- Laboratory Testing: Types of Tests, Testing for Pregnant Women, Testing for Infants -- What CDC is Doing: Domestic Activities: Activities in Puerto Rico; International Activities -- CDC Foundation.Centers for Disease Control and Prevention (U.S.). Emergency Operations Center. Joint Information Center.
oai:cdc.stacks:cdc:13224
2017-02-06T12:32:19Z
Centers for Disease Control and Prevention], National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis EliminationMultidrug-resistant tuberculosis: (MDR TB)MDR TBeng2 p. : digital, PDF file (380.91 KB, 2 p.)electronic resourceTextPatient Education Handouthttp://stacks.cdc.gov/view/cdc/13224/Tuberculosis, Multidrug-ResistantTuberculosis, Multidrug-Resistant--Patient Education HandoutNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) Division of Tuberculosis Elimination.Tuberculosis (TB) is a disease caused by bacteria that are spread from person to person through the air. TB usually affects the lungs, but it can also affect other parts of the body, such as the brain, the kidneys, or the spine. In most cases, TB is treatable and curable; however, persons with TB can die if they do not get proper treatment. Multidrug-resistant TB (MDR TB) is caused by an organism that is resistant to at least isoniazid and rifampin, the two most potent TB drugs. These drugs are used to treat all persons with TB disease.What is tuberculosis (TB)? -- What is multidrug-resistant tuberculosis (MDR TB)? -- What is extensively drug resistant tuberculosis (XDR TB)? -- How is TB spread? -- How does drug resistance happen? -- Who is at risk for getting MDR TB? -- How can MDR TB be prevented? -- Is there a vaccine to prevent TB? -- What should I do if I think I have been exposed to someone with TB disease? -- What are the symptoms of TB disease? -- Additional InformationMay 2012.CS229616 MMode of access: World Wide Web.United States
oai:cdc.stacks:cdc:5883
2017-02-06T12:33:02Z
Centers for Disease Control and Prevention, Division of Tuberculosis Elimination]Multidrug-resistant tuberculosis: (MDR TB)MDR TBeng2 p. : digital, PDF file (278 KB, 2 p.)electronic resourceTextPatient Education Handouthttp://stacks.cdc.gov/view/cdc/5883/Tuberculosis, Multidrug-ResistantTuberculosis, Multidrug-Resistant--Patient Education HandoutNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) Division of Tuberculosis Elimination."Multidrug-resistant TB (MDR TB) is TB that is resistant to at least two of the best anti-TB drugs, isoniazid and rifampicin. These drugs are considered first-line drugs and are used to treat all persons with TB disease." - p. 1April 2010.Mode of access: World Wide Web.United States
oai:cdc.stacks:cdc:40604
2017-02-06T13:34:42Z
SARS coronavirus (SARS-CoV), Urbani straineng17 unnumbered pagescdc:40604http://stacks.cdc.gov/view/cdc/40604/Genome, ViralSARS Virus/geneticsSevere Acute Respiratory Syndromebases 1 to 29727nucleoseq.pdfBellini, William J.Campagnoli, ,R. P.Icenogle, Joseph P.Monroe, Stephan S.Nix, W. AllanOberste, M. StevenPallansch, Mark A.Rota, Paul A.CDC SARS Coronavirus Sequencing TeamNational Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases.
oai:cdc.stacks:cdc:44061
2017-02-06T16:17:23Z
Casos de zika reportados nos Estados Unidos [1 de fevereiro de 2017]Zika cases reported in the United States [Portuguese]Transmissão ativa do zika vÃrus na Flóridapor1 mapcdc:44061http://stacks.cdc.gov/view/cdc/44061/Communicable Diseases, EmergingZika Virus Infection/epidemiology2 de fevereiro de 2017Zika cases reported in the United States [Portuguese]Casos de enfermedad por el virus del Zika confirmados en laboratorio e informados a ArboNET por estado o territorio (al 1 de fevereiro de 2017)Transmissão ativa do zika vÃrus na FlóridaFloridaMiami Beach (Fla.)Wynwood (Miami, Fla.)United StatesNational Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.ArboNET
oai:cdc.stacks:cdc:44062
2017-02-06T16:17:36Z
Casos de zika informados en los Estados Unidos [al 1 de febrero del 2017]Zika cases reported in the United States [Spanish]Transmisión activa del virus del Zika en Floridaspa1 mapcdc:44062http://stacks.cdc.gov/view/cdc/44062/Communicable Diseases, EmergingZika Virus Infection/epidemiology2 de febrero del 2017Zika cases reported in the United States [Spanish]Casos de enfermedad por el virus del Zika, confirmados en laboratorio, informados a ArboNET, por estado o territorio (al 1 de febrero del 2017)Transmisión activa del virus del Zika en FloridaFloridaMiami Beach (Fla.)Wynwood (Miami, Fla.)United StatesNational Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.ArboNET
oai:cdc.stacks:cdc:44060
2017-02-06T20:26:16Z
Cancer registrieseng1 postercdc:44060http://stacks.cdc.gov/view/cdc/44060/NeoplasmsRegistriesCancer RegistriesTrack and monitor cancer trends over time and provide vital information for allocating resources, implementing prevention, screening and treatment programs, and evaluating the impact and effectiveness of cancer programs and policiesGlobal Cancer BurdenIn 2012 there were 14.1 million new cancer cases, which is estimated to rise 54% by 2030• 57% New cancer cases• 65% cancer deaths• 46% Living with cancersSource: Globocan 2012, World Health OrganizationScarcity of Cancer DataPercentage of population covered by high quality cancer registries• 95% North America• 8% Latin America and Caribbean• 2% Africa• 42% Europe• 6% Asia• 78% OceaniaSource: The Cancer Atlas, American Cancer SocietyFactors that Affect Costs 1• Cancer registries can improve operations and efficiency• Size of area served• Data collection procedures (paper vs. electronic)• Volume of cases• Quality of Data available• Number of reporting sources• Staff turnover and training requirements• Cost of living• Organization/funding structureCost at the Population Level2Spread over the population covered by the registries, registry costs per person are lowCost per person (lowest to highest in study)India• Mumbai, less than 1 centUganda• Kampala, 1 cent• Kenya• Nairobi, 3 centsColombia• Barranquilla, 5 cents• Bucaramanga, 11 cents• Manizales, 13 cents• Cali, 18 cents• Pasto, 22 centsTo learn more, visit http://www.cancerepidemiology.netU.S. Department of Health and Human ServicesCenters for Disease Control and Prevention1Subramanian, Sujha et al. Developing and testing a cost data collection instrument for noncommunicable disease registry planning. Cancer Epidemiology, 2016.2Tangka, Florence et al. Resource requirements for cancer registration in areas with limited resources: Analysis of cost data from four low- and middle-income countries. Cancer Epidemiology, 2016.cancer_registries_cost_infographic_handout_cdc_final12_22_16.pdfCenter for Global Health (U.S.)
oai:cdc.stacks:cdc:44063
2017-02-06T20:26:16Z
Rules of the game for food safetyeng1 postercdc:44063http://stacks.cdc.gov/view/cdc/44063/Food HandlingFood SafetyFood StorageFootballRules of the Game for Food Safety• Keep it clean.o Before you eat or handle food, wash your hands, food prep tools and surfaces.• Cook to the right temperature.o Use a food thermometer to check that foods are cooked to the right temperature:• 165° for chicken• 160° for beef• Watch the clock.o Throw out perishable food that has been sitting at room temperature for more than two hours; one hour if it's 90°F or warmer.• Serve at the right temperature.o Keep hot foods at 140°F or warmer.o Keep cold foods at 40°F or colder.CS272887-BNational Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases.
oai:cdc.stacks:cdc:36284
2017-02-08T20:20:34Z
Reply: CDC analysis of ICSI/autism: association is not
causationHum ReprodHum Reprod. 30(7):1746.cdc:36284http://stacks.cdc.gov/view/cdc/36284/ArticleAutistic DisorderFemaleFertilization in VitroHumansInfertility, FemaleInfertility, MaleMaleSperm Injections, IntracytoplasmicCC999999/Intramural CDC HHS/United States2016-07-01T00:00:00Z25976658PMC4608223Kissin, Dmitry M.Zhang, YujiaBoulet, Sheree L.Fountain, ChristineBearman, PeterSchieve, LauraYeargin-Allsopp, MarshalynJamieson, Denise J.
oai:cdc.stacks:cdc:44054
2017-02-08T20:20:36Z
Association of MHC region SNPs with irritant susceptibility in healthcare workersJ ImmunotoxicolJ Immunotoxicol. 13(5):738-744.cdc:44054http://stacks.cdc.gov/view/cdc/44054/ArticleGeneticshealthcare workersirritant contact dermatitisMHCIrritant contact dermatitis is the most common work-related skin disease, especially affecting workers in "wet-work" occupations. This study was conducted to investigate the association between single nucleotide polymorphisms (SNPs) within the major histocompatibility complex (MHC) and skin irritant response in a group of healthcare workers. 585 volunteer healthcare workers were genotyped for MHC SNPs and patch tested with three different irritants: sodium lauryl sulfate (SLS), sodium hydroxide (NaOH) and benzalkonium chloride (BKC). Genotyping was performed using Illumina Goldengate MHC panels. A number of SNPs within the MHC Class I (OR2B3, TRIM31, TRIM10, TRIM40 and IER3), Class II (HLA-DPA1, HLA-DPB1) and Class III (C2) genes were associated (p < 0.001) with skin response to tested irritants in different genetic models. Linkage disequilibrium patterns and functional annotations identified two SNPs in the TRIM40 (rs1573298) and HLA-DPB1 (rs9277554) genes, with a potential impact on gene regulation. In addition, SNPs in PSMB9 (rs10046277 and ITPR3 (rs499384) were associated with hand dermatitis. The results are of interest as they demonstrate that genetic variations in inflammation-related genes within the MHC can influence chemical-induced skin irritation and may explain the connection between inflamed skin and propensity to subsequent allergic contact sensitization.CC999999/Intramural CDC HHS/United StatesZ99 ES999999/Intramural NIH HHS/United States2017-02-02T00:00:00Z27258892PMC5289286Yucesoy, BerranTalzhanov, YerkebulanBarmada, M. MichaelJohnson, Victor J.Kashon, Michael L.Baron, ElmaWilson, Nevin W.Frye, BonnieWang, WeiFluharty, KaraGharib, RolaMeade, JeanGermolec, DoriLuster, Michael I.Nedorost, Susan
oai:cdc.stacks:cdc:7546
2017-02-09T12:43:00Z
Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning WorkgroupMMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease ControlMMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control.
2000; 49(RR-4):1-14.http://stacks.cdc.gov/view/cdc/7546/Biological WarfareChemical WarfareDisaster PlanningUnited StatesViolenceThe U.S. national civilian vulnerability to the deliberate use of biological and chemical agents has been highlighted by recognition of substantial biological weapons development programs and arsenals in foreign countries, attempts to acquire or possess biological agents by militants, and high-profile terrorist attacks. Evaluation of this vulnerability has focused on the role public health will have detecting and managing the probable covert biological terrorist incident with the realization that the U.S. local, state, and federal infrastructure is already strained as a result of other important public health problems. In partnership with representatives for local and state health departments, other federal agencies, and medical and public health professional associations, CDC has developed a strategic plan to address the deliberate dissemination of biological or chemical agents. The plan contains recommendations to reduce U.S. vulnerability to biological and chemical terrorism--preparedness planning, detection and surveillance, laboratory analysis, emergency response, and communication systems. Training and research are integral components for achieving these recommendations. Success of the plan hinges on strengthening the relationships between medical and public health professionals and on building new partnerships with emergency management, the military, and law enforcement professionals.OTHERPUBLIC HEALTH PREPAREDNESS AND RESPONSERETIRED
oai:cdc.stacks:cdc:44086
2017-02-09T20:05:53Z
Variety, Enjoyment, and Physical Activity Participation Among High School StudentsJ Phys Act HealthJ Phys Act Health. 13(2):223-230.cdc:44086http://stacks.cdc.gov/view/cdc/44086/ArticleadolescentsyouthguidelinesrecommendationsAdolescentCross-Sectional StudiesExerciseFemaleHappinessHumansMaleNutrition SurveysRecreationSelf ReportSportsStudentsBackgroundFederal guidelines state that youth should participate in a variety of physical activity (PA) they find enjoyable. Little is known, however, about how variety and enjoyment are associated with PA participation among adolescents.MethodsData came from the 2010 National Youth Physical Activity and Nutrition Survey, a nationally representative survey of adolescents. Path analysis was used to examine the association of a variety of self-reported PA, defined as the number of activities and activity types (ie, team sports/weightlifting, individual activities, and other competitive/recreational sports), on self-reported PA enjoyment and participation. The analysis also examined whether enjoyment mediates the association between a variety of PA and participation. Separate models were estimated for boys and girls.ResultsNumber of activities was associated with increased PA enjoyment and participation. For boys and girls, team sports/weightlifting was associated with increased participation, and individual activities were indirectly associated with increased participation through enjoyment. For boys, team sports/weightlifting was indirectly related with participation.ConclusionsThese findings suggest that participation in a variety of PA is associated with increased PA enjoyment and participation. Providing opportunities for adolescents to engage in a variety of activities might help them identify PA they enjoy and facilitate lifelong PA habits.CC999999/Intramural CDC HHS/United States2017-02-07T00:00:00Z26107142PMC5295133Michael, Shannon L.Coffield, EdwardLee, Sarah M.Fulton, Janet E.
oai:cdc.stacks:cdc:44084
2017-02-09T20:05:53Z
Beyond Body Mass Index: Advantages of Abdominal Measurements for Recognizing Cardiometabolic DisordersAm J MedAm J Med. 129(1):74-81.e2.cdc:44084http://stacks.cdc.gov/view/cdc/44084/ArticleBody mass indexEpidemiologic measurementsHypercholesterolemiaHypertensionSagittal abdominal diameterAdiposityAdultBody Mass IndexCardiovascular DiseasesFemaleHumansMaleMetabolic DiseasesMiddle AgedNutrition SurveysObesitySex FactorsWaist CircumferenceYoung AdultBACKGROUNDThe clinical recognition of cardiometabolic disorders might be enhanced by anthropometry based on the sagittal abdominal diameter (SAD; also called “abdominal height�) or waist circumference rather than on weight. Direct comparisons of body mass index (BMI, weight/height2) with SAD/height ratio (SADHtR) or waist circumference/height ratio (WHtR) have not previously been tested in nationally representative populations.METHODSNonpregnant adults without diagnosed diabetes (ages 20–64 years; n = 3071) provided conventional anthropometry and supine SAD (by sliding-beam caliper) in the 2011–2012 US National Health and Nutrition Examination Survey. Population-weighted, logistic models estimated how strongly each anthropometric indicator was associated with 5 cardiometabolic disorders: Dysglycemia (glycated hemoglobin ≥5.7%), HyperNonHDLc (non-high-density-lipoprotein [HDL] cholesterol ≥4.14 mmol/L, or taking anticholesteremic medications), Hypertension (systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg, or taking antihypertensive medications), HyperALT (alanine transaminase ≥p75 [75th percentile, sex-specific]), and HyperGGT (gamma-glutamyltransferase ≥p75 [sex-specific]).RESULTSAfter scaling each indicator, adjusted odds ratios (aORs) tended to be highest for SADHtR and lowest for BMI when identifying each disorder except dysglycemia. When SADHtR entered models simultaneously with BMI, the aORs for BMI no longer directly identified any condition, whereas SADHtR identified persons with HyperNonHDLc by aOR 2.78 (95% confidence interval [CI], 1.71–4.51), Hypertension by aOR 2.51 (95% CI, 1.22–5.15), HyperALT by aOR 2.89 (95% CI, 1.56–5.37), and HyperGGT by aOR 5.43 (95% CI, 3.01–9.79). WHtR competed successfully against BMI with regard to Dysglycemia, Hyper-NonHDLc, and HyperGGT. c-Statistics of SADHtR and WHtR were higher than those of BMI (P <.001) for identifying HyperNonHDLc and HyperGGT.CONCLUSIONSAmong nonelderly adults, SADHtR or WHtR recognized cardiometabolic disorders better than did the BMI.CC999999/Intramural CDC HHS/United States2017-02-06T00:00:00Z26302146PMC5292922Kahn, Henry S.Bullard, Kai McKeever
oai:cdc.stacks:cdc:5723
2017-02-10T15:05:16Z
U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and HealthPan American Health Organization, National Smelting Company, Oruro, Boliviaengii, 44 p. : ill. ; 28 cm.printTextbibliographyhttp://stacks.cdc.gov/view/cdc/5723/Empresa Nacional de FundicioÌ?nes (Bolivia)Empresa Nacional de FundicioÌ?nes (Bolivia)Work environmentWork environment--Bolivia--OruroSick building syndromeSick building syndrome--Bolivia--OruroMetalworking industries--Employees--Health and hygieneMetalworking industries--Employees--Health and hygiene--Bolivia--OruroMetalworking industries--Environmental aspectsMetalworking industries--Environmental aspects--Bolivia--OruroAir Pollutants, Occupational--analysisAir Pollutants, Occupational--analysis--BoliviaAir Pollution, Indoor--analysisAir Pollution, Indoor--analysis--BoliviaMetals--bloodMetals--urineOccupational Exposure--analysisSulfur Dioxide--analysisHE20.7125 /2:94-0109 -2494HE 20.7125/2:94-0109-2494HE 20.7125/2:94-0109-2494National Institute for Occupational Safety and Health"In response to a request from the Pan American Health Organization (PAHO), an investigation was begun into possible exposures to heavy metals and sulfur-dioxide (7446095) at Empresa Metalurigica Vinto (SIC-3339), a large tin smelter near Oruro, Bolivia. Fifteen workers were selected for exposure monitoring. Of the 15, 14 had exposures greater than the NIOSH Recommended Exposure Limit or the OSHA Permissible Exposure Level to arsenic; 11 had hazardous exposures to cadmium (7440439), and eight had hazardous exposures to sulfur-dioxide. Surfaces throughout the facility were highly contaminated with heavy metals. Fifteen workers participated in biological monitoring studies. The median value for urinary arsenic (7440382) (UA) was 78 micrograms per gram creatinine. Nine of the 15 workers had UA levels exceeding the American Conference of Governmental Industrial Hygienists Biological Exposure Index. The median blood lead (7439921) level was 19 micrograms per deciliter. The authors conclude that a significant health hazard from exposures to heavy metals and sulfur-dioxide exists for some of the employees at this location. The authors recommend that measures be taken to control the hazards, including further study of exposure, implementing engineering controls, improving hygiene facilities, implementing medical surveillance programs, and improving respiratory protection programs. (A Spanish language version of this publication is available. See NTIS-PB95-261061). =" - NIOSHTIC-2Shipping list no.: 95-0164-P."January 1995"--P. [1].NIOSH investigators: Aaron Sussell, Mitchell Singal.Also available via the World Wide Web.Includes bibliographical references (p. 26-28).BoliviaOruroBoliviaOruroBoliviaOruroBoliviaOruroBoliviaBoliviaBoliviaSingal, Mitchell.Sussell, Aaron.
oai:cdc.stacks:cdc:35372
2017-02-10T21:14:59Z
Anthrax surface sampling instructor guideDHHS publication ; Â (NIOSH)eng44 numbered pageshttp://stacks.cdc.gov/view/cdc/35372/AnthraxBacillus AnthracisEnvironmental MonitoringEpidemiological MonitoringSpores, BacterialThis training provides instructions for the collection of environmental Bacillus anthracis spores, or anthrax, from nonporous surfaces using macrofoam swabs and cellulose sponges. Read the entire Instructor Guide before facilitating Anthrax Surface Sampling training. There are materials and supplies that must be included in the training, some of which require preparation in advance. The training consists of a segment of lecture with demonstration, followed by guided practice (Exercise), where the instructor and an experienced sampler will observe and coach participants as they perform practice sampling.Suggested citation: NIOSH [2015]. NIOSH Workplace Design Solutions: supporting Prevention through Design (PtD) using business value concepts. By Biddle E, Afanuh S. Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. DHHS (NIOSH) Publication No. 2015-198.NIOSHTIC No 20046772508-instructorguidefinal09.30.2014.pdfAfanuh, SusanBiddle, Elyce AnneNational Institute for Occupational Safety and Health.
oai:cdc.stacks:cdc:34561
2017-02-13T12:54:02Z
Shifts in global health security : lessons from Ebolaeng64 numbered slideshttp://stacks.cdc.gov/view/cdc/34561/Communicable Disease ControlDisease Outbreaks/prevention & controlHemorrhagic Fever, Ebola/prevention & controlPublic HealthWorld HealthGlobal health security is the protection of the health of people and societies worldwide. With diseases a plane ride or border crossing away, the importance of global health security has never been clearer. Patterns of global travel and trade pose greater opportunities for infectious diseases to emerge and spread nearly anywhere within 24 hours. The Ebola epidemic in West Africa, which has infected more than 28,000 people across 10 countries and has caused more than 11,200 deaths, highlights the importance of ensuring that every country is prepared to prevent, detect, and respond to outbreaks and emerging health threats. Disease threats also have a devastating impact on economies. A recent World Bank economic analysis estimated that Guinea, Liberia and Sierra Leone, will lose at least $2.2 billion in 2015 as a result of the epidemic.Global health security must be a shared responsibility with collaboration within countries and across many organizations and governments. In 2005, 194 countries collaborated to revise a set of health policy rules called the International Health Regulations (IHR), establishing greater global health security capacity than ever before. But although all member states signed on to the IHR, by the end of 2014, only 64 countries reported being fully prepared to detect and respond to disease threats. We have also seen an emergence and spread of new infectious threats and a rise of drug resistance in microbes. In the wake of Ebola, it is clear that every nation must undertake public health surveillance and support basic public health infrastructure.In this session of Public Health Grand Rounds we discuss how CDC, other U.S. government agencies, and global partners are working to promote global health security as an international priority and accelerate progress toward a world safe and secure from epidemics of infectious disease.Tuesday, September 29, 2015 at 1pm EST.Presented by: Jordan W. Tappero, MD, MPH
, Captain, US Public Health Service, Director, Division of Global Health Protection, Center for Global Health, CDC ["The Global Health Security Agenda and the West Africa Ebola Epidemic"]; Jennifer Nuzzo, DrPH, SM
, Senior Associate
UPMC Center for Health Security ["Ebola Successes and Challenges and What they Mean for Future Health Security Threats"]; David L. Blazes, MD, MPH
, Director, Military Tropical Medicine, US Department of Defense, Professor, Tropical Public Health, Uniformed Services University of the Health Sciences, US Navy Specialty Leader, Infectious Diseases, Navy Medicine Professional Development Center ["Infectious Disease Surveillance and Global Security"].Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds.september292015.pdfEbola successes and challenges and what they mean for future health security threats [PDF version of the PowerPoint presentation by Jennifer B. Nuzzo, p. 2-32] -- Global health security: disease surveillance and diagnostic capacity [PDF version of the PowerPoint presentation by David L. Blazes, p. 33-53] -- The Global health security agenda and the West Africa Ebola epidemic [PDF version of the PowerPoint presentation by Jordan W. Tappero, p. 54-85.Tappero, Jordan W.Nuzzo, Jennifer B.Blazes, David L.Iskander, John K.Thorpe, PhoebeLaird, SusanCenters for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication.Center for Global Health (U.S.). Division of Global Health Protection,
oai:cdc.stacks:cdc:32962
2017-02-13T12:55:35Z
Smoking in GATS countries infographicSmoking in Global Adult Tobacco Survey countires.eng1 infographichttp://stacks.cdc.gov/view/cdc/32962/Health SurveywsSmoking/epidemiologyWorld HealthSmoking in Global Adult Tobacco Survey countries688 million people smoke in 22 GATS countries.Center for Global Health (U.S.)
oai:cdc.stacks:cdc:30583
2017-02-13T12:56:03Z
We need to reach every childeng1 infographicKnow more hepatitishttp://stacks.cdc.gov/view/cdc/30583/Communicable Disease ControlVaccinationWorld HealthIn 2013, 21.8 million babies did not receive the 3rd doses of vaccinations needed to protect them against preventable but deadly diseases – that’s 1 out of every 5 babies unprotected.70% of these babies live in only 10 countries: India, Nigeria, Pakistan, Ethiopia, Democratic Republic of Congo, Indonesia, Vietnam, Mexico, South Africa and Kenya.We can reach every child with all recommended life-saving vaccinations, no matter where he or she lives, by improving: health worker training and practices, caregiver knowledge and practices, vaccine supply and forecasting, vaccination sessions near communities, and using data to take action.Center for Global Health (U.S.)
oai:cdc.stacks:cdc:30585
2017-02-13T12:56:33Z
Meningitis Aeng1 infographicKnow more hepatitishttp://stacks.cdc.gov/view/cdc/30585/Meningitis, MeningococcalWorld Healthdeadly, expensive and preventable.Meningitis A threatens the lives of 450 million people across 26 countries in Africa’s “Meningitis Belt,� mostly children and young adults.The sub-Saharan meningitis belt stretches from Senegal and the Gambia in the West to Ethiopia in the East.Meningitis kills within hours.Thousands die in years with large outbreaks.1 in 10 die within 2 days even when antibiotics are available.1 in 4 survivors are left with permanent disabilities such as paralysis, blindness, hearing loss, seizures, and intellectual disability.Meningitis treatment is costly for both families and nations and contributes to the cycle of poverty.Each case of meningitis in a family results in a sudden cost of about US$90 – what is about 3 or 4 months of the family’s disposable income.The permanent disabilities caused by meningitis leave survivors less able to care for themselves and less likely to earn income.The MenAfriVac® vaccine protects against meningitis A saving lives and money.MenAfriVac® became available for use in Africa in 2010 priced at just US$0.40 per dose. Over 217 million people had received the vaccine by the end of 2014.Prevention costs US$0.40 per person versus treatment costs US$90 per person.The vaccine is targeted to protect 450 million people at risk from meningitis by 2016 and save nearly 150,000 lives.MenAfriVac® is the first vaccine for use in Africa that can be transported and stored for as long as 4 days without refrigeration or even an ice pack. This saves money and allows for safe delivery to people in even the most remote areas.The introduction of the new vaccine is a giant step toward achieving the elimination of epidemic meningitis as a public health problem in sub-Saharan Africa.CS247141Africa South of the SaharaCenter for Global Health (U.S.)
oai:cdc.stacks:cdc:12075
2017-02-13T13:03:40Z
U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and PreventionRecommendations of the International Task Force for Disease Eradicationengv, 38 p. ; 22 cm.printTextbibliographyhttp://stacks.cdc.gov/view/cdc/12075/Medicine, PreventiveDiseases--TreatmentWorld healthCommunicable Disease ControlDisease EradicationInternational CooperationWorld HealthInternational Task Force for Disease EradicationThis report summarizes the conclusions of the International Task Force for Disease Eradication (ITFDE), a group of scientists who were convened by a secretariat at the Carter Center of Emory University six times during 1989-1992. The purpose of the ITFDE was to establish criteria and apply them systematically to evaluate the potential eradicability of other diseases in the aftermath of the Smallpox Eradication Program. The ITFDE defined eradication as “reduction of the worldwide incidence of a disease to zero as a result of deliberate efforts, obviating the necessity for further control measures.� The names of the members of the ITFDE, the criteria they developed and used, and summaries of the papers that were presented to the ITFDE by various experts are included in this report, as well as a brief history of the concept of disease eradication since the late 19th century. The ITFDE considered more than 90 diseases and reviewed 30 of these in depth, including one noninfectious disease. It concluded that six diseases--dracunculiasis, poliomyelitis, mumps, rubella, lymphatic filariasis, and cysticercosis--could probably be eradicated by using current technology. It also concluded that manifestations of seven other diseases could be “eliminated,� and it noted critical research needs that, if realized, might permit other diseases to be eradicated eventually. The successful eradication of smallpox in 1977 and the ongoing campaigns to eradicate dracunculiasis by 1995 and poliomyelitis by 2000 should ensure that eradication of selected diseases will continue to be used as a powerful tool of international public health.Introduction -- -- A Spectrum of Disease Control -- -- A Brief History of Disease Eradication -- -- Summary of the ITFDE Deliberations -- Diseases targeted for eradication -- Diseases that could potentially be eradicated -- Diseases of which some aspect could be eliminated -- Diseases that are not eradicable now -- Diseases that are not eradicable -- -- The Future -- APPENDIX 1. Diseases screened for potential eradicability by the International Task Force for Disease Eradication"December 31, 1993"--Cover.Includes bibliographical references (p. 24-25).Centers for Disease Control and Prevention (U.S.)Emory University Carter Center.
oai:cdc.stacks:cdc:39068
2017-02-13T13:47:30Z
A Decade of progress : the President’s Malaria Initiative : tenth annual report to Congresseng88 numbered pagescdc:39068http://stacks.cdc.gov/view/cdc/39068/International CooperationMalaria/economicsMalaria/prevention & controlWorld HealthThe year 2015 marks a decade of renewed U.S. Govern ment leadership and commitment in the global malaria fight. The past decade witnessed a key turning point in the long battle against malaria, and we have reached several historic milestones. Global progress on malaria control has been unequivocal – the World Health Organization estimates that more than 6.2 million malaria deaths were averted world wide between 2000 and 2015.1 Most of these estimated lives saved were among children under the age of five living in sub-Saharan Africa – the most vulnerable group at risk for malaria. During this time period, new malaria cases fell by 37 percent, and malaria mortality declined by an estimated 48 percent worldwide. Even greater reductions in malaria mortality were recorded in sub-Saharan Africa, where deaths among children under the age of five declined by 71 percent. Based on these results, the World Health Organiza tion and UNICEF reported that the Millennium Development Malaria Goal of halting and reversing malaria incidence by 2015 was achieved.pmi-reports/pmi-tenth-annual-report-congress.pdfAbbreviations and acronyms -- Executive summary -- 1. Outcomes and impact: a decade of progress -- 2. Achieving and sustaining scale of proven interaction -- 3. Adapting to changing epidemiology and incorporating new tools -- 4. Improving countries’ capacity to collect and use information -- 5. Mitigating risk against the current malaria control gains -- 6. Building capacity and health systems -- 7. Global and U.S. government partnerships for ensuring success -- Appendix 1. PMI funding FY 2006–FY 2015 -- Appendix 2. PMI contributions summary -- Appendix 3. Mortality rates and intervention coverage in PMI focus countries.
oai:cdc.stacks:cdc:22449
2017-02-13T13:48:17Z
President’s Malaria Initiative : eighth annual report to Congresseng51 numbered pageshttp://stacks.cdc.gov/view/cdc/22449/International CooperationMalaria/economicsMalaria/prevention & controlWorld HealthAcross sub-Saharan Africa, where countries have scaled up insecticide treated mosquito nets (ITNs), indoor residual spraying (IRS), improved diagnostic tests, and highly effective antimalarial drugs, mortality in children under five years of age has fallen dramatically. The risk of malaria is declining, and it is apparent that the cumulative efforts by the President’s Malaria Initiative (PMI), national governments, The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), and many other partners are working. According to the World Health Organization’s (WHO’s) 2013 World Malaria Report, the malaria mortality rates in children under years of age in Africa were reduced by an estimated 54 percent between 2000 and 2012. Over the same period, the estimated number of malaria cases in all age groups in Africa dropped from 174 million to 165 million, together with a decrease in deaths due to malaria from 802,000 to 562,000. The U.S. Government’s financial and technical contributions have played a major role in this remarkable progress.Abbreviations and acronyms -- Executive summary -- 1. Outcomes and impact -- 2. Malaria prevention -- 3. Malaria diagnosis and treatment -- 4. Global and U.S. government partnerships for ensuring success -- Appendix 1. PMI funding FYs 2006-2013 -- Appendix 2. PMI contribution summary -- Appendix 3. Mortality rates and intervention coverage in PMI focus countries.Prevention and ControlInfectious DiseasePresident's Malaria Initiative (U.S.)United States, Agency for International Development.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:30605
2017-02-13T13:49:03Z
President’s Malaria Initiative : ninth annual report to Congressengii, 55 numbered pageshttp://stacks.cdc.gov/view/cdc/30605/International CooperationMalaria/economicsMalaria/prevention & controlWorld HealthThe fight against malaria is making historic gains across sub-Saharan Africa. In countries where insecticide-treated mosquito nets (ITNs), indoor residual spraying (IRS), improved diagnostic tests, and highly effective antimalarial drugs have been scaled up, mortality rates in children under five years of age have fallen markedly. According to the World Health Organization’s (WHO’s) 2014 World Malaria Report, in Africa, between 2000 and 2013, the estimated number of malaria cases in all age groups decreased from 174 million to 163 million. The estimated malaria mortality rate in children under five decreased by 58 percent in the Africa region between 2000 and 2013, while the scale-up of malaria control interventions over the same period resulted in an estimated 4.3 million fewer malaria deaths globally.These successes in reducing malaria’s burden are the result of a tremendous increase in financing for malaria control and the expansion of malaria control interventions. The cumulative ef- forts of the President’s Malaria Initiative (PMI), national govern- ments, the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), and many other partners are clearly working. The U.S. Government’s financial and technical contributions, through PMI, have been key in this remarkable progress. In the nearly 10 years since it was launched, PMI has garnered recognition as a highly effective program that successfully combines solid support at the country level with global leadership on malaria prevention and control with other funding and technical partners.Abbreviations and acronyms -- Executive summary -- 1. Outcomes and impact -- 2. Malaria prevention -- 3. Malaria diagnosis and treatment -- 4. Global and U.S. government partnerships for ensuring success -- Appendix 1. PMI funding FY 2006–FY 2014 -- Appendix 2. PMI contribution summary -- Appendix 3. Mortality rates and intervention coverage in PMI focus countries.President's Malaria Initiative (U.S.)United States, Agency for International Development.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:41786
2017-02-13T13:52:59Z
CDC’s strategic framework for global Immunization, 2016–2020eng37 numbered pagescdc:41786http://stacks.cdc.gov/view/cdc/41786/ImmunizationImmunization ProgramsVaccinesWorld Health• Vision and Mission• Foreword• Overview• Background• Strategic Framework Goals, Priorities, and Objectives:o GOAL 1: Control, eliminate, or eradicate vaccine-preventable diseases to reduce death and disability globallyo GOAL 2: Strengthen country ownership, policy and practices, and partnershipso GOAL 3: Ensure quality of vaccination delivery to achieve high and equitable coverageo GOAL 4: Strengthen surveillance and immunization information to prevent, detect, and respond to VPDso GOAL 5: Conduct and promote research, innovation, and evaluation• ReferencesPlease cite the following document as: Centers for Disease Control and Prevention. CDC’s Strategic Framework for Global Immunization, 2016–2020 Atlanta, GA: May 2016 www.cdc.gov/globalhealth/immunizationCS265122global-immunization-framework-508.pdfCenters for Disease Control and Prevention (U.S.)Center for Global Health (U.S.). Global Immunization Division.
oai:cdc.stacks:cdc:21942
2017-02-13T13:54:27Z
CDC global maternal and child health strategy 2013-2016eng18 numbered pageshttp://stacks.cdc.gov/view/cdc/21942/Child Health ServicesHealth PolicyMaternal Health ServicesWorld HealthThis CDC Global Maternal and Child Health (MCH) Strategy provides a comprehensive framework for global MCH efforts at CDC. It promotes an integrated approach to the implementation of interventions that support MOH programs in countries and advance achievement of global MCH goals. It emphasizes strength- ening public health related components of the health system that are important to achieving MCH goals. The strategy aims to ensure that CDC’s technical and programmatic expertise is leveraged for maximum impact to reduce maternal and child morbidity and mortality. It focuses on women’s health from preconception through postpartum, and children’s health from the perinatal period through the fourth year.The strategy builds upon existing MCH activities implemented by Centers/Institutes/Offices and by CDC’s country offices in collaboration with Ministries of Health and partners. CDC has a breadth and depth of expertise in MCH from both domestic and global MCH work that can contribute to the final “big push� to reach the Millennium Development Goals launched during the 2012 United Nationals General Assembly meeting.CDC’s Global MCH Strategy has two primary goals consistent with United States government and global MCH targets: the reduction of morbidity and mortality among children under five years (under-5) and the reduction of maternal and perinatal morbidity and mortality. To support achievement of these goals and ensure sustainability, a third goal is to strengthen health systems necessary for MCH. The fourth goal, strengthened partnerships, supports achievement of the first three goals.OtherReproductive HealthCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:23122
2017-02-13T14:05:20Z
Division of Public Health Systens abd Workforce Development 2009 annual reportengv, 99 numbered pageshttp://stacks.cdc.gov/view/cdc/23122/Center for Global Health (U.S.). Division of Public Health Systems and Workforce Development.Capacity BuildingEpidemiology/educationEpidemiology/manpowerInternational CooperationField Epidemiology Laboratory Training ProgramField Epidemiology Training ProgramProgram DevelopmentPublic HealthWorld HealthIn 2009, the U.S. Centers for Disease Control and Prevention (CDC) went through an agency-wide reorganization that led to a restructuring of our division and resulted in a name change. Our Divi- sion of Global Public Health Capacity Development was renamed Division of Public Health Systems and Workforce Development. This organizational restructuring more accurately reflects CDC’s new goal in the arena of global public health and allows us to better work with partners to strengthen capacity of countries around the world to improve their public health systems and build up their public health workforce.Throughout these organizational changes, we remain committed to spearhead efforts to improve global health through medical technology, international coalitions, government interventions, and basic behavior changes.Two of our long-standing programs are the Field Epidemiology Training Program (FETP) and the Field Epidemiology and Laboratory Training Program (FELTP), which are modeled after CDC’s Epi- demic Intelligence Service. Since 1980, these programs have been growing steadily and we have helped establish more than 30 FETPs or FELTPs that have produced more than 2,000 graduates. As of December 2009, we are supporting 12 FETPs or FELTPs, covering 23 countries, with the help of 14 resident advisors who provide direct program support on the ground. We are also in the process of establishing new programs in 7 regions, totaling 12 countries.Another major component of our work resides in helping countries develop or strengthen the management skills of their public health leaders through targeted country management capacity building programs. We are currently leading efforts in six countries. These programs are developed by our division’s Sustainable Management Development Program.Director’s letter -- Division overview -- Division-supported FETPs and FELTPs -- FELTPs in development -- Self-sustained FETPs and FELTPs -- Management capacity building programs -- Other division projects -- Appendices: Publications and presentations; Frequently used acronyms.Center for Global Health (U.S.). Division of Public Health Systems and Workforce Development.
oai:cdc.stacks:cdc:41769
2017-02-13T14:09:11Z
The Urgent threat of TB drug resistance : drug resistant TB threatens to erase decades of progresseng2 unnumbered pagescdc:41769http://stacks.cdc.gov/view/cdc/41769/Tuberculosis, Multidrug-ResistantWorld HealthOne-third of the world’s population is infected with TB, and 10.4 million people become sick with active TB disease each year. TB is among the leading causes of death from infectious disease globally and claims 1.8 million lives each year, even though we have had a cure for more than 70 years. In some cases of TB, the bacteria that causes infection has been able to develop resistance to the anti-TB drugs used to cure it. Most often, this stems from incomplete treatment of non- resistant TB. In recent decades, these strains have become resistant to more and more of our best drugs and continue to spread globally. Drug-resistant TB strains are more difficult to cure and costly to our economy and health system. Because TB is airborne and contagious, the continued spread of drug-resistant TB could cause a resurgence of TB in parts of the world where TB is currently less common, including the United States.dght_mdr-tb_factsheet_10-14-2016_ck_v3.pdfNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
oai:cdc.stacks:cdc:40453
2017-02-13T14:23:21Z
Patient information sheet and sonsent For long term specimen storage (SARS-Cov EIA testing)eng1 unnumbered, 2 numbered pagescdc:40453http://stacks.cdc.gov/view/cdc/40453/Consent FormsImmunoenzyme TechniquesSevere Acute Respiratory Syndrome/diagnosisSevere Acute Respiratory Syndrome/prevention & controlSpecimen HandlingThe Centers for Disease Control and Prevention (CDC) and public health laboratories are using an investigational laboratory test to test for the virus that causes “severe acute respiratory syndrome� or (SARS). The Food and Drug Administration (FDA) has not licensed this test. The FDA has agreed that we can use this test as part of the public health response to SARS. We don’t know for sure if this test can find all people who may get sick with SARS. There are no FDA approved tests that quickly find the virus.Your State or Local Health Department and CDC are using the results of this test as one piece of information to help us find out if people are sick with SARS and to limit the spread of this illness. Your (or your child’s) doctor will use other information along with this test result to decide what is best for you (your child).Because SARS can be a serious illness, your State or Local Health Dept and/or CDC have used this test on samples from you (your child).eia-patient.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:6035
2017-02-13T14:29:20Z
Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Office of Mine Safety and Health ResearchDemands on the knee during kneeling and squatting activities common to low-seam miningeng47 p. : col. ill. ; 28 cm.printTextbibliographyhttp://stacks.cdc.gov/view/cdc/6035/Knee--Safety appliancesKnee--Wounds and injuries--PreventionMine safety--Equipment And Supplies"In 2009, the operating height of approximately one fourth of underground coal mines in the U.S. restricted mine workers to kneeling, crawling, and/or stooping posture to perform work [MSHA 2009). The large number of knee injuries to these workers is likely attributed to exposure to musculoskeletal disorder risk factors (prolonged kneeling, crawling, and twisting on one's knees). Therefore, the National Institute for Occupational Safety and Health has investigated three different biomechanical parameters (muscle activity of the knee flexors and extensors, pressure at the knee, and the net forces and moments at the knee) as subjects assumed postures common to low-seam mining, both with and without kneepads. The postures evaluated included: (I) kneeling near full flexion; (2) kneeling near 90 degrees of knee flexion; (3) kneeling on one knee; and (4) squatting. The pressure and the net forces and moments at the knee were evaluated as subjects statically assumed these postures. However, negligible muscle activity existed for these static postures. Therefore, muscle activity of the knee flexors and extensors was evaluated for each posture while subjects performed a lateral lift that is common to low-seam mining where they lifted a 25-lb block from their right side, transferred it across their body, and placed it on the ground on their left side. The results indicated that, relative to the stresses posed by other kneeling postures, some postures had may have more detrimental effects than others. Considering the potential impact of the three biomechanical parameters, several key recommendations were made regarding when it may be most appropriate to use specific postures. Additional recommendations were also made regarding the design of kneepads." - p. 1Susan M. Moore, Jonisha P. Pollard, William L. Porter, Sean Gallagher, Alan G. Mayton."June 2011."Accompanying CD contains the full text of the circular and the instructor's guide, as well as various supplementary materials in digital formats (posters, flyers, information sheets, PowerPoint presentation slides, and short videos in .wmv format demonstrating recommendations given in the texts).Also available via the World Wide Web as an Acrobat .pdf file (1.828 KB, 55 p.).Includes bibliographical references (p. 39-41).Gallagher, Sean.Mayton, Alan G.Moore, Susan M.Pollard, Jonisha P.Porter, William L.National Institute for Occupational Safety and HealthNational Institute for Occupational Safety and Health Office of Mine Safety and Health Research.
oai:cdc.stacks:cdc:13683
2017-02-13T15:18:14Z
Department of Health and Human Services, Centers for Disease Control and PreventionSevere acute respiratory syndrome: frequently asked questions about SARSFrequently asked questions about SARSeng4 p. : digital, PDF fileelectronic resourcTextPatient Education HandoutPopular Workshttp://stacks.cdc.gov/view/cdc/13683/Severe Acute Respiratory SyndromeSevere Acute Respiratory Syndrome--Popular WorksCenters for Disease Control and Prevention (U.S.)Severe acute respiratory syndrome (SARS) is a viral respiratory illness that was recognized as a global threat in March 2003, after first appearing in Southern China in November 2002.The Disease -- What is SARS? -- What are the symptoms and signs of SARS? -- What is the cause of SARS? -- How is SARS spread? -- What does close contact mean? -- If I were exposed to SARS-CoV, how long would it take for me to become sick? -- How long is a person with SARS contagious? -- Is a person with SARS contagious before symptoms appear? -- What medical treatment is recommended for patients with SARS? -- If there is another outbreak of SARS, how can I protect myself? -- -- Current SARS Situation, 2004 -- What is the current SARS situation in the world? -- -- SARS-associated coronavirus -- What are coronaviruses? -- If coronaviruses usually cause mild illness in humans, how could this new coronavirus be responsible for a potentially life-threatening disease such as SARS? -- How long can SARS-CoV survive in the environment? -- -- Laboratory Testing -- Is there a laboratory test for SARS? -- What is a PCR test? -- What does serologic testing involve? -- What does viral culture and isolation involve?April 26, 2004.Mode of access: Internet from the CDC web site as Acrobat .pdf file (173.82 KB, 4 p. ).
oai:cdc.stacks:cdc:8280
2017-02-13T16:02:35Z
Proceedings Of The Second International Workshop On Coal Pillar Mechanics And Designhttp://stacks.cdc.gov/view/cdc/8280/NIOSHPillar design is the first line of defense against rock falls—the greatest single safety hazard faced by underground coal miners in the United States and abroad. To help advance the state of the art in this fundamental mining science, the National Institute for Occupational Safety and Health organized the Second International Workshop on Coal Pillar Mechanics and Design. The workshop was held in Vail, CO, on June 6,1999, in association with the 37th U.S. Rock Mechanics Symposium. The proceedings include 15 papers from leading ground control specialists in the United States, Canada, Australia, the United Kingdom, and the Republic of South Africa. The papers address the entire range of issues associated with coal pillars and have a decidedly practical flavor. Topics include numerical modeling, empirical design formulas based on case histories, field measurements, and post failure mechanics.
oai:cdc.stacks:cdc:8348
2017-02-13T16:28:42Z
Analysis Of Mine Fires For All U. S. Metal/Nonmetal Mining Categories, 1990-2001http://stacks.cdc.gov/view/cdc/8348/NIOSHThis report analyzes mine fires for all U.S. underground and surface metal/nonmetal mining categories during 1990-2001 by state and six successive 2-year time periods. Injury risk rates are derived, and ignition source, methods of detection and suppression, and other variables are examined. Fires involving contractors are also included in the analysis. The data were derived from Mine Safety and Health Administration (MSHA)mine fire accident publications and verbal communications with mine personnel. The analysis will provide the National Institute for Occupational Safety and Health, MSHA, and the mining industry with a better understanding of the causes and hazards associated with mine fires and an increased awareness aimed at preventing and reducing fire hazards. It will also form a basis for future fire research programs.De Rosa, Maria I.
oai:cdc.stacks:cdc:8578
2017-02-13T16:37:59Z
Final Report Of The Technical Study Panel On The Utilization Of Belt Air And The Composition And Fire Retardant Properties Of Belt Materials In Underground Coal Mining - Executive Summaryhttp://stacks.cdc.gov/view/cdc/8578/NIOSHThe Technical Study Panel on the Utilization of Belt Air and the Composition and Fire Retardant Properties of Belt Materials in Underground Coal Mining (hereafter referred to as the Panel or the TSP) was established by Section 11 of the Mine Improvement and New Emergency Response Act of 2006 (MINER Act). The Panel was charged with providing independent scientific and engineering review and recommendations with respect to the utilization of belt air and the composition and fire retardant properties of belt materials in underground coal mining. The TSP was impaneled by the Honorable Elaine L. Chao and commenced its work on January 9, 2007. At this first meeting, Mr. Richard E. Stickler, Assistant Secretary of Labor for Mine Safety and Health, asked the Panel to report on many issues including how recent technological advances could be applied to atmospheric monitoring systems, point-type heat sensors, current state of fire-resistant vs. fireproof belt materials, and belt fire suppression systems to improve miner safety. In addition, Mr. Stickler asked the Panel to review belt air velocity limitations. The Panel members attended 12 days of public meetings over a nine-month period. Three of the public meetings were scheduled for the Panel to hear from technical experts and those persons or organizations interested in providing input. The meetings were held in Coraopolis, Pennsylvania with emphasis on belt fires, belt maintenance, belt flammability and toxicity, ventilation, and escape issues; in Salt Lake City with emphasis on ground control and convergence issues; and in Birmingham with emphasis on fire detection, sensors and atmospheric monitoring systems. National Institute for Occupational Safety and Health (NIOSH) researchers, Mine Safety and Health Administration (MSHA) personnel, representatives of the major belt conveyor manufacturers and a representative of the National Mining Association provided discussions at the Coraopolis meeting. In Salt Lake City, Utah, MSHA district managers and ventilation specialists, a member of the Aracoma Mine No. 1 investigation team, a representative of the Bureau of Land Management, and industry and consulting representatives of the Utah Mining Association and the Colorado Mining Association made presentations. In Birmingham, Alabama, atmospheric monitoring system representatives, NIOSH researchers, representatives of coal mining companies, and UMWA workers from two Alabama mining companies made presentations. In addition, a staff member of The Center for Regulatory Effectiveness also presented comments to the Panel. In conjunction with the meetings in Salt Lake City and Birmingham, three-member subcommittees of the Technical Study Panel made field visits to the Skyline Mine, the Aberdeen Mine, and the Jim Walter Resources Mine No. 4. The mine visits were scheduled to see first-hand the mining conditions under which belt air was being utilized as an additional source of intake air for working sections.
oai:cdc.stacks:cdc:35715
2017-02-14T15:08:33Z
CoÌ?mo cuidar a pacientes con dengue en el hogar : coÌ?mo atender a un familiar enfermoHomecare for dengue patients : how to care for your sick family member [Spanish]spacdc:35715http://stacks.cdc.gov/view/cdc/35715/Dengue Hemorrhagic Fever/therapyHomecare for dengue patients : how to care for your sick family member [Spanish]Su hijo o familiar podriÌ?a tener dengue. Es importante que lo observe con cuidado ya que el paciente con dengue puede agravarse raÌ?pidamente entre el tercer y el seÌ?ptimo diÌ?a de la enfermedad, cuando la fiebre esteÌ? desapareciendo. Su meÌ?dico puede ordenar pruebas de laboratorio para determinar si su familiar enfermo tiene dengue.Mantenga el nombre y teleÌ?fono de su meÌ?dico a mano, y llame si tiene preguntas.Como-cuidar-a-pacientes-con-dengue-en-el-hogar.pdfNational Center for Zoonotic, Vector-Borne and Enteric Diseases (U.S.). Division of Vector Borne Infectious Diseases.
oai:cdc.stacks:cdc:44165
2017-02-14T19:54:48Z
Pandemic preparedness and response at CDCeng23 unnumbered slidescdc:44165http://stacks.cdc.gov/view/cdc/44165/Disaster PlanningDisease OutbreaksInfluenza, HumanPresentation delivered Tuesday, September 16, 2007 at the Avian Influenza Conference, September 16-19, 2007, Bethesda, Maryland.Publication date from document properties.pandemic_preparedness_and_response_at_cdc_508.pdfRubin, Carol H.National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.)�Avian Influenza Conference (September 16-19, 2007 : Bethesda, Maryland)
oai:cdc.stacks:cdc:44166
2017-02-14T19:54:54Z
National Center for Preparedness, Detection, and Control of Infectious Diseaseseng26 unnumbered slidescdc:44166http://stacks.cdc.gov/view/cdc/44166/Presentation delivered Thursday, Sept. 11, 2008 at the ASTHO-NACCHO Joint Conference, September 9-12, 2008, Sacramento, CA.Publication date from document properties.Khabbaz, Rima F.National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.)�ASTHO-NACCHO Joint Conference (September 9-12, 2008 : Sacramento, CA)
oai:cdc.stacks:cdc:44139
2017-02-14T19:55:14Z
Preguntas frecuentes sobre el SRASFrequently asked questions about SARS [Spanish]spa4 numbered pagescdc:44139http://stacks.cdc.gov/view/cdc/44139/SARS VirusSevere Acute Respiratory Syndrome26 de abril del 2004Frequently asked questions about SARS [Spanish]El sÃndrome respiratorio agudo severo (SRAS) (en inglés: Severe Acute Respiratory Syndrome, SARS) es una enfermedad respiratoria viral que fue identificada como una amenaza global en marzo de 2003, después de su aparición inicial en el sureste de China en noviembre de 2002.faq-sp.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44141
2017-02-14T19:55:26Z
Gearing up for the travel season : how clinicians can ensure their patients are packed with knowledge on Zika preventioneng73 unnumbered slidescdc:44141http://stacks.cdc.gov/view/cdc/44141/TravelZika Virus InfectionClinician Outreach and Communication Activity (COCA) conference call Thursday, December 8, 2016Throughout this holiday season, many clinicians will see patients who plan to travel or have recently traveled to areas with active Zika transmission. During this COCA Call, clinicians will learn about current CDC travel recommendations, how to determine which patients should receive Zika testing after traveling to an area with Zika, and the recommendations for patients before and after travel to help them protect themselves and others from Zika.Zika virus : Gearing up for the travel season : how to ensure your patients are packed with knowledge on Zika prevention / Mary Tanner -- Zika virus transmission and prevention / Allison Taylor Walker.Tanner, MaryWalker, Allison TaylorCenters for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of Emergency Operations.National Center of Emerging and Zoonotic Infectious Diseases (U.S.). Division of Global Migration and Quarantine. Travelers’ Health Branch.
oai:cdc.stacks:cdc:44128
2017-02-14T19:55:40Z
First National Symposium on Medical and Public Health Response to Bioterrorismengp. 491-565cdc:44128http://stacks.cdc.gov/view/cdc/44128/BioterrorismDisaster PlanningEmergency Medical ServicesOn February 16-17, 1999, in Arlington, Virginia, 950 public health officials, physicians, and other medical personnel, along with government, military, and intelligence experts gathered for the first National Symposium on Medical and Public Health Response to Bioterrorism. Participants were geographically diverse. Represented were 46 states, plus Washington, D.C., and 10 countries: Australia, Austria, Canada, England, Finland, France, Germany, Israel, Italy, and the Netherlands.The guiding force behind the symposium was the newly established Johns Hopkins Center for Civilian Biodefense Studies, which hopes the discussions will lead to a framework and partnership for strategic planning. The other main sponsors were the Department of Health and Human Services, Infectious Diseases Society of America, and American Society for Microbiology. Twelve other public health professional societies supported the conference.About the First National Symposium on Medical and Public Health Response to Bioterrorism / D.A. Henderson -- Bioterrorism: How Prepared Are We? / Donna E. Shalala -- The Emerging Threat of Bioterrorism / James M. Hughes -- View from the Hill: Congressional Efforts to Address Bioterrorism / S. Anthony McCann -- Finding the Right Balance against Bioterrorism / Richard A. Clarke -- Historical Trends Related to Bioterrorism: An Empirical Analysis / Jonathan B. Tucker -- The Threat of Biological Attack: Why Concern Now? / David W. Siegrist -- Nuclear Blindness: An Overview of the Biological Weapons Programs of the Former Soviet Union and Iraq / Christopher J. Davis -- Aum Shinrikyo: Once and Future Threat? / Kyle B. Olson -- The Prospect of Domestic Bioterrorism / Jessica Stern -- Potential Biological Weapons Threats / Mark G. Kortepeter and Gerald W. Parker -- Epidemiology of Bioterrorism / Julie A. Pavlin -- Vaccines in Civilian Defense Against Bioterrorism / Philip K. Russell -- Vaccines, Pharmaceutical Products, and Bioterrorism: Challenges for the U.S. Food and Drug Administration / Kathryn C. Zoon -- Smallpox: Clinical and Epidemiologic Features / D. A. Henderson -- Smallpox: An Attack Scenario / Tara O’Toole -- Aftermath of a Hypothetical Smallpox Disaster / Jason Bardi -- Clinical and Epidemiologic Principles of Anthrax / Theodore J. Cieslak and Edward M. Eitzen, Jr. -- Anthrax: A Possible Case History / Thomas V. Inglesby -- Applying Lessons Learned from Anthrax Case History to Other Scenarios / John G. Bartlett -- Addressing Bioterrorist Threats: Where Do We Go From Here? / Margaret A. Hamburg.Henderson, Donald A. (Donald Ainslie), 1928-2016.Shalala, Donna E.Hughes, James M.McCann, S. AnthonyClarke, Richard A.Tucker, Jonathan B.Siegrist, David W.Davis, Christopher J.Olson, Kyle B.Stern, JessicaKortepeter , Mark G.Parker, Gerald W.Pavlin, Julie A.Russell, Philip K.Zoon, Kathryn C.O’Toole, TaraJason BardiCieslak, Theodore J.Eitzen, Edward M.Inglesby, Thomas V.Bartlett, John G.Hamburg, Margaret A.National Center for Infectious Diseases (U.S.)National Symposium on Medical and Public Health Response to Bioterrorism (1999 : Baltimore, MD)
oai:cdc.stacks:cdc:44129
2017-02-14T19:55:43Z
PulseNet news ; v. 4, issue 1, winter 2005eng6 numbered pagescdc:44129http://stacks.cdc.gov/view/cdc/44129/Disease OutbreaksFoodborne DiseasesFood ContaminationFood SatetyThe National Molecular Subtyping Network ofr Foodborne Disease Surveillance.State and local public health networks in the United States and PulseNet Canada.National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases. Foodborne and Diarrheal Diseases Branch.United States. Department of Agriculture.United States. Food and Drug Administration.Association of Public Health Laboratories (U.S.)
oai:cdc.stacks:cdc:44132
2017-02-14T19:55:55Z
ResumeÌ? de la dracunculose # 213, 16 juillet 2012ResumeÌ? de la dracunculosefre8 unnumbered pagescdc:44132http://stacks.cdc.gov/view/cdc/44132/Communicable Disease ControlDracunculiasis/prevention & controlDracunculus Nematode16 juillet 2012LE SOUDAN DU SUD : 49% DE CAS EN MOINS, AUCUN DANS LES EÌ?TATS LAKES/CENTRAL EQUATORIA JUSQU’AÌ€ PREÌ?SENTFrench version of: Guinea worm wrap-up # 214, July 16, 2012WHO Collaborating Center for Research, Training and Eradication of Dracunculiasis.Emory University. Carter Center.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44135
2017-02-14T19:56:09Z
NMI notes ; June 5, 2015National Notifiable Diseases Surveillance System Modernization Initiativeeng4 unnumbered pagescdc:44135http://stacks.cdc.gov/view/cdc/44135/Communicable Diseases/EpidemiologyData CollectionDisease Notification/methodsEpidemiologic MethodsPublic Health SurveillanceNMI Notes will provide monthly news updates about the National Notifiable Diseases Surveillance System (NNDSS) Modernization Initiative (NMI). It is a collaboration by the Centers for Disease Control and Prevention (CDC), Council of State and Territorial Epidemiologists (CSTE), and Association of Public Health Laboratories (APHL).Council of State and Territorial Epidemiologists.
oai:cdc.stacks:cdc:44136
2017-02-14T19:56:23Z
West Africa – Ebola outbreak fact sheet #5, fiscal year (FY) 2016eng5 numbered pagescdc:44136http://stacks.cdc.gov/view/cdc/44136/Disease OutbreaksEbolavirusHemorrhagic Fever, EbolaAfrica, WesternUnited States. Agency for International Development.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44137
2017-02-14T19:56:32Z
CDC Influenza Division key points ; December 9, 2016eng10 numbered pagescdc:44137http://stacks.cdc.gov/view/cdc/44137/Disease OutbreaksInfluenza, Human/epidemiologyPublic Health SurveillanceNational Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
oai:cdc.stacks:cdc:43956
2017-02-14T19:56:47Z
NSSP update ; January 2017National Syndromic Surveillance Program updateeng6 numbered pagescdc:43956http://stacks.cdc.gov/view/cdc/43956/Communicable Diseases/epidemiologyData CollectionDisease Notification/methodsEpidemiologic MethodsPublic Health SurveillanceNSSP Update provides monthly news updates about the National Syndromic Surveillance Program (NSSP). NSSP embodies collaboration, particularly in the development of its BioSense Platform, a secure cloud- based computing environment in which practitioners can share tools to rapidly collect, evaluate, store, and share data. NSSP Update will keep you in touch with the latest advancement in the platform’s development.Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Health Informatics and Surveillance.
oai:cdc.stacks:cdc:43957
2017-02-14T19:56:55Z
NNDSS Modernization Initiative biweekly update ; June 19, 2015National Notifiable Diseases Surveillance System Modernization Initiativeeng4 unnumbered pagescdc:43957http://stacks.cdc.gov/view/cdc/43957/Communicable Diseases/EpidemiologyData CollectionDisease Notification/methodsEpidemiologic MethodsPublic Health SurveillancePlease find below the National Notifiable Diseases Surveillance System (NNDSS) Modernization Initiative (NMI) Technical Assistance (TA) Coordination Team Update for June 19, 2015. These e-mail updates are a collaboration among the Centers for Disease Control and Prevention (CDC), Council of State and Territorial Epidemiologists (CSTE), and the Association of Public Health Laboratories (APHL) and will be sent biweekly in an effort to keep reporting jurisdictions and other partners and stakeholders updated on the progress of NMI.nmi-ta-update_6_19_2015.pdfCouncil of State and Territorial Epidemiologists.
oai:cdc.stacks:cdc:44107
2017-02-14T19:57:04Z
Health protection : urgent threatseng1 postercdc:44107http://stacks.cdc.gov/view/cdc/44107/ChronologyDisastersDisease OutbreaksGlobal HealthPublic HealthWorld Trade Center : Sept 2001Anthrax Attacks : Oct-Nov 01West Nile Virus : Aug-Nov 02Space Shuttle Columbia Disaster : Feb 03SARS : Mar-Aug 03RNC 2004 Aug 04MonkeyPox : June-Aug 03Northeast Blackout : Aug 03Hurricane Isabel : Sept 03Influenza : Sept 03Ricin, Tularemia, Anthrax : Oct-Nov 03California Wildfires : Oct-Nov 03BSE : Dec 03Avian Influenza : Jan-Mar 04Guam : Typhoon Feb 04Ricin Domestic Response : Feb 04G8 Summit : June 042004 Summer Olympics : June 04DNC 2004 : July 04RNC 2004 : Aug 04Hurricanes (Charley, Frances, Ivan, Jean) : Aug-Oct 04West Nile Virus : Aug-Nov 04Tsunami : Dec 04-Feb 05Influenza Vaccine Shortage : Oct 04-05Hurricane Wilma : Oct 04-PresentMarburgVirus : Mar 05-Sept 05Hurricane Katrina : Aug. 05 -presentHurricane Rita : Sept. 05 -presentE-ColiOutbreak : Sept-Oct 2006CDC – Protecting People’s HealthPublication date from document properties.c-paintingthepicture_508_04.pdfNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)
oai:cdc.stacks:cdc:44109
2017-02-14T19:57:18Z
Coordinating call centers for responding to pandemic influenza and other public health emergencies : a workbook for state and local plannersengv, 232 numbered pagescdc:44109http://stacks.cdc.gov/view/cdc/44109/Disaster PlanningHotlinesInfluenza, HumanPandemicsPublic HealthRegional PlanningIn October 2006 and March 2007, the U.S. Department of Transportation (DOT) National Highway Traffic Safety Administration (NHTSA) Office of Emergency Medical Services (OEMS) convened several stakeholder meetings to gather input and steer the development and clearance of two complementary guidance documents: Preparing for Pandemic Influenza: Recommendations for Protocol Development for 9-1-1 Personnel and Public Safety Answering Points (PSAPs) and EMS Pandemic Influenza Guidelines for Statewide Adoption. During these meetings, participants expressed an additional need to determine how 9-1-1 and Emergency Medical Services (EMS) would fit into the larger framework of public health and healthcare information lines. DOT/NHTSA and its partner U.S. Department of Health and Human Services (HHS) agencies concurred with those expressed concerns and agreed it would be beneficial to hold an additional meeting with an expanded group of stakeholders who provide healthcare or clinical information to the public via the telephone.In further discussions convened by the Centers for Disease Control and Prevention (CDC) Division of Healthcare Quality Promotion (DHQP), CDC National Center for Health Marketing (NCHM), DOT/NHTSA, and the Agency for Healthcare Research and Quality (AHRQ), several issues were identified that could be addressed during the expanded stakeholder meeting. Prior to the meeting, CDC DHQP and the Oak Ridge Institute for Science and Education (ORISE) engaged subject matter experts involved in call center coordination, call center technology, and telephone triage to determine which of the identified issues were most critical. Discussions highlighted large disparities in the services call centers are able to provide at the state and local levels, and identified a need for improving resource identification and coordination of call centers in communities at various levels of planning.Subsequently, an expanded stakeholder meeting was held in August 2008 to establish the framework for developing this workbook. The goal of the meeting was to identify the process for coordinating call centers during an influenza pandemic, identify issues and obstacles that may hinder the development of a coordinated call center system, and develop strategies to address these issues and obstacles. Following the meeting, ongoing discussions were held with these stakeholders throughout the development of this workbook.This document was prepared for the Centers for Disease Control and Prevention (CDC) by ORISE through an interagency agreement with DOE. ORISE is managed by Oak Ridge Associated Universities under DOE contract number DE-AC05-06OR23100.FinalCallCenterWorkbookForWeb.pdfeface -- Introduction -- Before You Begin -- Overview -- Getting Started -- Step1: Determine Where You Are -- Step 2: Determine Where You Need to Be -- Step3: Determine How You Are Going to Get There -- Step4: Develop Your Coordinated Call Center System -- Step5: Launch Your Coordinated Call Center System -- Step6: Maintain Your Coordinated Call Center System -- Conclusion -- Appendix A: Overview of the Incident Command System. -- Appendix B: Coordinating Public Information -- Appendix C: Overview of 2-1-1 -- Appendix D: Acknowledgements -- Appendix E: Resources. -- Appendix F: Abbreviations/Acronyms -- Appendix G: Glossary of Terms -- Extra Forms.DE-AC05-06OR23100National Center for Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.Oak Ridge Institute for Science and Education.United States. Department of Energy.
oai:cdc.stacks:cdc:44088
2017-02-14T19:58:00Z
Guidance on initial responses to a suspicious letter / container with a potential biological threateng6 numbered pagescdc:44088http://stacks.cdc.gov/view/cdc/44088/AnthraxBioterrorismPostal ServiceUNCLASSIFIED November 2, 2004This is an FBI – DHS – HHS/CDC Coordinated DocumentA large number of potentially suspicious letters and packages continue to be reported to federal, state, and local law enforcement and emergency response agencies nationwide. In some instances these letters or packages may include powders, liquids, or other materials. Federal, state, and local response agencies should be mindful of the potential for small-scale exposure, which could result from material contained in threatening or suspicious packages. While this guidance is generally focused on the initial response to potential biological threats, all personnel responding to such incidents must be aware of the potential for exposure to hazardous chemical and/or radiological materials in addition to biological hazards. Additionally, there may be a threat posed from secondary releases or devices. Consistent with established protocols, response agencies should follow standard law enforcement procedures and hazard risk assessments in response to calls, and should pre-identify the relevant local public health points of contact to be notified in the event of a potential bioterrorism event.The following guidelines are recommendations for local responders, based on existing procedures (including recommendations from the International Association of Fire Chiefs). This document provides guidance on the initial response to a suspicious letter/container, while other follow-on response plans, such as portions of the National Response Plan (NRP), may be utilized if a threat is deemed credible. In general, these potential threats or incidents fall into one of five general scenarios.suspicious-package-biothreat.pdfUnited States. Federal Bureau of Investigation.United States, Department of Homeland SecurityCenters for Diseases Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44090
2017-02-14T19:58:08Z
Hướng dẫn Tìm hiểu v� Bệnh Than (Anthrax) : Bệnh Truy�n nhiễm - Bệnh ThanGuide to understanding anthrax : infectious disease - anthrax [Vietnamese]vie8 numbered pagescdc:44090http://stacks.cdc.gov/view/cdc/44090/AnthraxGuide to understanding anthrax : infectious disease - anthrax [Vietnamese]Fact Sheet - Vietnamese - May 2016anthrax-evergreen-content-vietnamese-508.pdfNational Center for Emerging and Zoonotic Infectious Diseases (U.S.)
oai:cdc.stacks:cdc:44091
2017-02-14T19:58:19Z
Guia para compreender o Antraz : Doença infecciosa – AntrazGuide to understanding anthrax : infectious disease - anthrax [Portuguese]por8 numbered pagescdc:44091http://stacks.cdc.gov/view/cdc/44091/AnthraxGuide to understanding anthrax : infectious disease - anthrax [Portuguese]Fact sheet - Portuguese - May 2016anthrax-evergreen-content-portuguese-508.pdfNational Center for Emerging and Zoonotic Infectious Diseases (U.S.)
oai:cdc.stacks:cdc:44092
2017-02-14T19:58:26Z
Guide to understanding anthrax : infectious disease - anthrax [Korean]Guide to understanding anthrax : infectious disease - anthrax [Korean]kor8 numbered pagescdc:44092http://stacks.cdc.gov/view/cdc/44092/AnthraxGuide to understanding anthrax : infectious disease - anthrax [Korean]Fact Sheet - Korean - May 2016anthrax-evergreen-content-korean-508.pdfNational Center for Emerging and Zoonotic Infectious Diseases (U.S.)
oai:cdc.stacks:cdc:44093
2017-02-14T19:58:39Z
Gid pou konprann maladi chabon : Maladi Enfeksyon - Maladi chabonGuide to understanding anthrax : infectious disease - anthrax [Hatian Creole]hat8 numbered pagescdc:44093http://stacks.cdc.gov/view/cdc/44093/AnthraxGuide to understanding anthrax : infectious disease - anthrax [Hatian Creole]Maladi chabon se yon maladi enfeksyon grav ki soti nan bakteri yo teste pozitif pou gram, anfòm ti baton, yo rele Bacillus anthracis (Bacille chabon). Ou ka jwenn maladi chabon nan eta natirèl li nan tè epi li plis frape zannimo domestik ak sovaj nan lemonn antye. Byenke li ra nan peyi Etazini, moun ka tonbe malad ak maladi chabon si yo rantre ankontak ak zanmimo enfekte oswa pwodui zanmi kontamine. Kontak ak maladi chabon ka lakòz maladi grav lakay moun ansanm ak zannimo.Maladi chabon pa kontaje, sa vle di ou pa ka pran l tankou grip oswa rim.Fact sheet - Hatian Creole - May 2016anthrax-evergreen-content-haitian-508.pdfNational Center for Emerging and Zoonotic Infectious Diseases (U.S.)
oai:cdc.stacks:cdc:44094
2017-02-14T19:58:46Z
Guida sull’antrace : Malattie Infettive - AntraceGuide to understanding anthrax : infectious disease - anthrax [Italian]ita8 numbered pagescdc:44094http://stacks.cdc.gov/view/cdc/44094/AnthraxGuide to understanding anthrax : infectious disease - anthrax [Italian]Fact sheet - Italian - May 2016anthrax-evergreen-content-italian-508.pdfNational Center for Emerging and Zoonotic Infectious Diseases (U.S.)
oai:cdc.stacks:cdc:44096
2017-02-14T19:58:54Z
Guide pour comprendre l’anthrax : maladies infectieuses - l’anthraxGuide to understanding anthrax : infectious disease - anthrax [French]fre8 numbered pagescdc:44096http://stacks.cdc.gov/view/cdc/44096/AnthraxGuide to understanding anthrax : infectious disease - anthrax [French]L’anthrax est une maladie infectieuse grave causeÌ?e par des bacteÌ?ries aÌ€ Gram positif en forme de baÌ‚tonnets connues sous le nom de bacille du charbon ("Bacillus anthracis"). L’anthrax peut se trouver naturellement dans le sol et touche geÌ?neÌ?ralement les animaux domestiques et sauvages du monde entier. Bien qu’il soit rare aux EÌ?tats-Unis, les eÌ‚tres humains peuvent eÌ‚tre infecteÌ?s par l’anthrax s’ils entrent en contact avec des animaux infecteÌ?s ou s’ils sont contamineÌ?s par des produits d’origine animale. Le contact avec l’anthrax peut provoquer des maladies graves chez les humains et les animaux.L’anthrax n’est pas contagieux, ce qui signifie que vous ne pouvez pas l’attraper comme un rhume ou une grippe.Fact sheet - French - May 2016anthrax-evergreen-content-french-508.pdfNational Center for Emerging and Zoonotic Infectious Diseases (U.S.)
oai:cdc.stacks:cdc:44097
2017-02-14T19:58:58Z
Guide to understanding anthrax : infectious disease - anthraxeng8 numbered pagescdc:44097http://stacks.cdc.gov/view/cdc/44097/AnthraxAnthrax is a serious infectious disease caused by gram-positive, rod-shaped bacteria known as Bacillus anthracis. Anthrax can be found naturally in soil and commonly affects domestic and wild animals around the world. Although it is rare in the United States, people can get sick with anthrax if they come in contact with infected animals or contaminated animal products. Contact with anthrax can cause severe illness in both humans and animals.Anthrax is not contagious, which means you can’t catch it like the cold or flu.Fact Sheet - English - May 2016anthrax-evergreen-content-english.pdfNational Center for Emerging and Zoonotic Infectious Diseases (U.S.)
oai:cdc.stacks:cdc:44098
2017-02-14T19:59:02Z
Tuberculosis : get the factseng2 unnumbered pagescdc:44098http://stacks.cdc.gov/view/cdc/44098/Health EducationTuberculosisTuberculosis (TB) is a disease that usually affects the lungs. TB sometimes affects other parts of the body, such as the brain, the kidneys, or the spine. TB disease can cause death if it is not treated.CS260871APubliclation date from document properties.tuberculosis_get_the-facts.pdfNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.
oai:cdc.stacks:cdc:44099
2017-02-14T19:59:06Z
Uterine cancereng2 unnumbered pagescdc:44099http://stacks.cdc.gov/view/cdc/44099/Uterine NeoplasmsThere are five main types of cancer that affect a woman’s reproductive organs: cervical, ovarian, uterine, vaginal, and vulvar. As a group, they are referred to as gynecologic (GY-neh-kuh-LAH-jik) cancer. (A sixth type of gynecologic cancer is the very rare fallopian tube cancer.)This fact sheet about uterine cancer is part of the Centers for Disease Control and Prevention’s (CDC) Inside Knowledge: Get the Facts About Gynecologic Cancer campaign. The campaign helps women get the facts about gynecologic cancer, providing important “inside knowledge� about their bodies and health.uterine_facts.pdfNational Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
oai:cdc.stacks:cdc:44059
2017-02-14T19:59:22Z
Guidance about Severe Acute Respiratory Syndrome (SARS) for persons traveling to areas where SARS cases have been reportedeng2 numbered pagescdc:44059http://stacks.cdc.gov/view/cdc/44059/Severe Acute Respiratory SyndromeTravelDuring the 2003 global outbreak, most persons reported as SARS cases in the United States were exposed through foreign travel to countries with outbreaks of SARS, with only limited secondary spread to close contacts* such as family members and healthcare workers. Guidance for the management of SARS exposures in healthcare settings, as well as infection control precautions for SARS patients and their close contacts in household settings, is provided in Supplement I, Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) www.cdc.gov/ncidod/sars/guidance/I/index.htm.The following guidance is provided for persons (other than healthcare workers or household contacts) who are traveling to areas where SARS cases have been reported. These recommendations are based on the experience to date and may be revised as more information becomes available.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44035
2017-02-14T19:59:26Z
NMI notes ; January 2017National Notifiable Diseases Surveillance System Modernization Initiativeeng5 unnumbered pagescdc:44035http://stacks.cdc.gov/view/cdc/44035/Communicable Diseases/EpidemiologyData CollectionDisease Notification/methodsEpidemiologic MethodsPublic Health SurveillanceNMI Notes will provide monthly news updates about the National Notifiable Diseases Surveillance System (NNDSS) Modernization Initiative (NMI). It is a collaboration by the Centers for Disease Control and Prevention (CDC), Council of State and Territorial Epidemiologists (CSTE), and Association of Public Health Laboratories (APHL).Council of State and Territorial Epidemiologists.
oai:cdc.stacks:cdc:44036
2017-02-14T19:59:31Z
Sequence for donning personal protective equipment (PPE) = Secuencia para ponerse el equipo de protección personal (PPE) ; Sequence for removing personal protective equipment (PPE) = Secuencia para quitarse el equipo de protección personal (PPE)engspa1 postercdc:44036http://stacks.cdc.gov/view/cdc/44036/Cross Infection/prevention & controlDisease Transmission, Infectious/prevention & controlHealth PersonnelHospitalsPersonal Protective EquipmentSevere Acute Respiratory SyndromeIn English and Spanish.Publication date from document properties.ppeposter1322.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44037
2017-02-14T19:59:40Z
Drug diversion spreads infection from healthcare providers to pateientseng1 postercdc:44037http://stacks.cdc.gov/view/cdc/44037/Cross InfectionDisease OutbreaksHealth PersonnelInfectious Disease Transmission, Professional-to-PatientPatient SafetyPersonnel, HospitalPrescription Drug DiversionHealthcare provider with Hepatitis C or other bloodborne infection tampers with injectable drugContaminated injection equipment and supplies present in the patient care environmentExposure of patient results from use of contaminated drug or equipment for patient injection or infusionDrug diversion occurs when prescription medicines are obtained or used illegally by healthcare providers.FOR MORE INFORMATION, VISIT WWW.ONEANDONLYCAMPAIGN.ORGCDC_DrugDiversionGraphic_final_508Compliant.pdf
oai:cdc.stacks:cdc:44041
2017-02-14T19:59:54Z
Principais mensagens – doença causada pelo zika viÌ?rus : atualizado em 1o de fevereiro de 2017Key messages – Zika Virus Disease [Portuguese]por45 numbered pagescdc:44041http://stacks.cdc.gov/view/cdc/44041/Disease OutbreaksHealth CommunicationZika VirusZika Virus Infection1o de fevereiro de 2017Key messages – Zika Virus Disease [Portuguese]PARA USO EXTERNOFinalidade: este documento se destina ao uso interno e externo. O documento conteÌ?m mensagens principais claras a serem usadas no desenvolvimento de outros materiais.As informações atualizadas estão em azul.01/02/17PT_47885.pdfHistórico do zika -- Resumo sobre o surto -- Sintomas -- Transmissão: Transmissão por mosquito (vetor), Transmissão periconcepcional/intrauterina/perinatal, Transmissão sexual, Transfusão de sangue, Amamentação -- Teste e diagnóstico -- Tratamento -- Prevenção: Como prevenir a transmissão pelo mosquito: Repelente de insetos, Controle de mosquitos em casa, Mosquitos modificados, Pulverização aérea; -- Como prevenir a transmissão sexual; Como prevenir a infecção do zika durante a gravidez: Recomendações para casais planejando a gravidez -- Como evitar gravidez não planejada durante um surto do zika virus; Triagem de sangue para detecção do zika virus: Levantamento em Porto Rico nos centros de coleta de sangue -- Efeitos sobre a saúde associados ao zika: Microcefalia: Diagnóstico de microcefalia, Piriproxifeno -- SÃndrome de Guillain-Barré -- Zika e os Estados Unidos: Registros de gravidez com zika; Relatório nacional: Mulheres grávidas e resultados -- Zika e territórios dos EUA -- Zika e Colômbia -- Recomendações de viagem: Avisos de viagens internacionais e em territórios dos EUA no exterior; Viagem para o Sudeste Asiático; Orientação de viagem doméstica (aplica-se ao território contÃguo dos Estados Unidos e HavaÃ), Viagem à Flórida -- Orientações e recomendações do CDC para profissionais de saúde: Profissionais de saúde da área obstétrica: Amniocentese, Diagnóstico pré-natal de microcefalia; Profissionais de saúde da área pediátrica: Defeitos congênitos, PossÃveis resultados e prognósticos, Orientação clÃnica; Controle de infecção -- Testes em laboratório: Tipos de testes: Testes para mulheres grávidas, Testes para bebês -- O que o CDC está fazendo: Atividades domésticas: Atividades em Porto Rico; Atividades internacionais -- CDC Foundation.Centers for Disease Control and Prevention (U.S.). Emergency Operations Center. Joint Information Center.
oai:cdc.stacks:cdc:44020
2017-02-14T20:00:08Z
National Program of Cancer Registries program standards, 2012-2017 (updated January 2013)eng7 numbered pagescdc:44020http://stacks.cdc.gov/view/cdc/44020/NeoplasmsRegistriesThe following are CDC’s Program Standards for the National Program of Cancer Registries (NPCR). These standards are based on authority provided to the CDC under the Public Health Service Act (Title 42, Chapter 6A, Sub-Chapter II, Part M, § 280e) and subsequent amendments, and apply to all reportable cancers as defined in the Act and amendments. The CDC NPCR Program Standards may change during the project period of the cooperative agreement.Publication date from document properties.npcr_standards.pdfNational Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.National Program of Cancer Registries.
oai:cdc.stacks:cdc:44022
2017-02-14T20:00:20Z
Pacific Northwest Agricultural Safety and Health CenterDHHS publication ; no. (NIOSH)eng1 unnumbered pagecdc:44022http://stacks.cdc.gov/view/cdc/44022/AgricultureAgricultural Workers' DiseasesOccupational HealthSafetyThe Pacific Northwest Agricultural Safety and Health Center (PNASH) is one of 11 agricultural research and prevention centers funded by the National Institute for Occupational Safety and Health. Founded in 1996, PNASH addresses local needs for our farming, fishing, and forestry work forces, and is now entering a new cycle (2016-2021) with multiple innovative research projects. PNASH works with partners in industry, labor, health services, professional organizations, and academia.We focus on the needs of vulnerable populations including women, farmworkers, and immigrant forestry workers. Our current priorities include:• Reducing exposure to high-risk pesticides in agricultural work and communities• Preventing heat-related illness among agricultural workers• Addressing serious injuries among dairy, forestry, and commercial fishing workersNorthwestern United StatesNational Institute for Occupational Safety and Health.
oai:cdc.stacks:cdc:44023
2017-02-14T20:00:24Z
Central States Center for Agricultural Safety and HealthDHHS publication ; no. (NIOSH)eng1 unnumbered pagecdc:44023http://stacks.cdc.gov/view/cdc/44023/AgricultureAgricultural Workers' DiseasesOccupational HealthSafetyThe Central States Center for Agricultural Safety and Health (CS-CASH) is one of 11 agricultural education, research and prevention centers funded by the National Institute for Occupational Safety and Health. CS-CASH has just completed the first cooperative agreement period (2011-2016) and is entering the second (2016-2021) with new research projects. CS-CASH works with partners in industry, labor, trade associations, professional organizations, and academia, focusing on these areas:• Protecting respiratory health of agricultural workers exposed to dust, gases, and mists.• Preventing hearing loss among agricultural workers in noisy environments.• Preventing traumatic injury among farmers and ranchers working in production agriculture.Midwestern United StatesNational Institute for Occupational Safety and Health.
oai:cdc.stacks:cdc:44024
2017-02-14T20:00:28Z
Great Plains Center for Agricultural HealthDHHS publication ; no. (NIOSH)eng1 unnumbered pagecdc:44024http://stacks.cdc.gov/view/cdc/44024/AgricultureAgricultural Workers' DiseasesOccupational HealthSafetyThe Great Plains Center for Agricultural Health (GPCAH) is one of 10 agricultural education, research and prevention centers funded by the National Institute for Occupational Safety and Health. GPCAH has just completed one cooperative agreement period (2011-2016) and is entering a new period (2016-2021) with new research projects. GPCAH’s goal is to reduce the burden of workplace injury and illness among Midwest farmers. Current priorities are to:• Reduce traumatic injuries from roadway crashes with agricultural equipment• Reduce exposures to air contaminants for livestock workers• Reduce musculoskeletal disorders among farmworkersMidwestern United StatesNational Institute for Occupational Safety and Health.
oai:cdc.stacks:cdc:44025
2017-02-14T20:00:31Z
Northeast Center for Occupational Health and SafetyDHHS publication ; no. (NIOSH)eng1 unnumbered pagecdc:44025http://stacks.cdc.gov/view/cdc/44025/AgricultureAgricultural Workers' DiseasesOccupational HealthSafetyThe Northeast Center for Occupational Health and Safety (NEC) is one of 11 agricultural education, research and prevention centers funded by the National Institute for Occupational Safety and Health (NIOSH). NEC has just completed one cooperative agreement period (2011-2016) and is entering a new period (2016-2021) with new research projects. NEC partners with other NIOSH centers, state and federal agencies, land grant universities, medical centers, and advocacy groups and other not-for-profit organizations to carry out research, safety trainings, and intervention programs aimed at reducing occupational injuries in agriculture, commercial fishing, and forestry (AFF) industries.New EnglandNational Institute for Occupational Safety and Health.
oai:cdc.stacks:cdc:44026
2017-02-14T20:00:35Z
Southwest Center for Agricultural Health, Injury Prevention and EducationDHHS publication ; no. (NIOSH)eng1 unnumbered pagecdc:44026http://stacks.cdc.gov/view/cdc/44026/AgricultureAgricultural Workers' DiseasesOccupational HealthSafetyThe Southwest Center for Agricultural Health, Injury Prevention and Education (SW Ag Center) is one of 11 agricultural education, research and prevention centers funded by the National Institute for Occupational Safety and Health. The SW Ag Center recently completed its 4th cooperative agreement period (2011-2016) and entered its 5th funding cycle (2016-2021) with new research projects. SW Ag Center works with partners in industry, labor, trade associations, professional organizations, and academia. Significant work has focused on these areas:• Preventing injuries and fatalities among commercial fishermen• Characterizing and preventing injuries among forestry and logging workers• Reducing pesticide exposure among farmworkersSouthwestern United StatesNational Institute for Occupational Safety and Health.
oai:cdc.stacks:cdc:44027
2017-02-14T20:00:39Z
Western Center for Agricultural Health and SafetyDHHS publication ; no. (NIOSH)eng1 unnumbered pagecdc:44027http://stacks.cdc.gov/view/cdc/44027/AgricultureAgricultural Workers' DiseasesOccupational HealthSafetyThe Western Center for Agricultural Health and Safety (WCAHS) is one of 11 agricultural education, research and prevention centers funded by the National Institute for Occupational Safety and Health. Based at the University of California, Davis (UC Davis), WCAHS has just completed one cooperative agreement period (2011-2016) and is entering a new period (2016-2021) with new research and outreach projects. The Center works with partners in industry, labor, trade associations, professional organizations, and academia, and focuses on reducing adverse health outcomes among immigrant farmworkers. The Center’s main priorities include:• Promoting respiratory health• Preventing heat illness• Preventing toxic exposures• Preventing musculoskeletal disordersArizonaCaliforniaHawaiiNevadaNational Institute for Occupational Safety and Health.
oai:cdc.stacks:cdc:44028
2017-02-14T20:00:44Z
National Center on Birth Defects and Developmental Disabilities annual report, Fiscal Year 2016 : includes special featureon NCBDDD’s Zika virus responseeng41 numbered pagescdc:44028http://stacks.cdc.gov/view/cdc/44028/Child Development Disorders, Pervasive/prevention & controlCongenital Abnormalities/prevention & controlDevelopmental Disabilities/prevention & controlHealth PromotionMicrocephalyPregnancy Complications/prevention & controlZika Virus InfectionThis report documents a year’s accomplishments and forward progress toward our vision in what has been a highly critical year for NCBDDD. A year we remember for many reasons and one that saw NCBDDD do something it has never done before—be at the forefront of a public health emergency response: CDC’s emergency response to Zika virus. The spread of Zika virus necessitated a global effort from public health, clinicians, laboratorians, and mosquito control experts. At the center of this effort, dedicated people from NCBDDD worked long hours—days, nights, weekends, and holidays—from our headquarters and traveling to other nations to render assistance and unraveling mysteries of the virus to help protect babies and pregnant women.Publication date from document properties.ncbddd-fiscal-year-2016-annual-report.pdfMessage from the Director -- NCBDDD’s Zika Virus Response -- Saving Babies Through Birth Defects Prevention and Research -- Helping Children Live to the Fullest by Understanding Developmental Disabilities -- Protecting People and Preventing Complications of Blood Disorders -- Improving Health of People with Disabilities -- Fiscal Year 2016 Budget -- Select State-Based Activities and Funding.National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Office of the Director.
oai:cdc.stacks:cdc:44029
2017-02-14T20:00:51Z
Marijuana legalization in Indian countryeng6 numbered pagescdc:44029http://stacks.cdc.gov/view/cdc/44029/Indians, North AmericanLegislation As TopicMarijuana Smoking/legislation & jurisprudenceThe following resources discuss topics related to marijuana legalization in Indian Country, 20 including tribal law and governance related to marijuana and federal and state laws that might affect marijuana legalization in Indian Country. Resources related to the tribal industrial hemp industry, which is often used as a framework for discussion of potential tribal marijuana industries, are also provided.This document was developed by Austin Charles, JD candidate 2018, Georgia State University College of Law, Summer 2016 Intern; Hillary Li, JD candidate 2017, University of North Carolina Chapel Hill School of Law, Fall 2016 extern; and Aila Hoss, JD, Carter Consulting, Inc., contractor with the Public Health Law Program (PHLP) within the Office for State, Tribal, Local and Territorial Support at the Centers for Disease Control and Prevention (CDC).resources-marijuana.pdfCharles, AustinLi, HillaryHoss, AilaPublic Health Law Program (Centers for Disease Control and Prevention (U.S.)); Centers for Disease Control and Prevention (U.S.). Office for State, Tribal, Local and Territorial Support.
oai:cdc.stacks:cdc:43997
2017-02-14T20:00:55Z
Ä?ôÌ?i vÆ¡Ì?i PhuÌ£ Huynh: XeÌ?t Nghiệm Vi RuÌ?t Zika DuÌ›oÌ›ng TiÌ?nh : Ä?iều Ä‘oÌ? coÌ? nghĩa giÌ€ đôÌ?i vÆ¡Ì?i con toÌ‚i?For parents: a positive Zika virus test : what does it mean for my child? [Vietnamese]vie2 numbered pagescdc:43997http://stacks.cdc.gov/view/cdc/43997/ChildrenParentsZika Virus Infection/diagnosisngaÌ€y 14 thaÌ?ng 03 năm 2016For parents: a positive Zika virus test : what does it mean for my child? [Vietnamese]QuyÌ? viÌ£ vÆ°Ì€a Ä‘ược thoÌ‚ng baÌ?o tÆ°Ì€ baÌ?c sĩ nhi khoa hoặc nhaÌ€ cung câÌ?p diÌ£ch vuÌ£ chăm soÌ?c sÆ°Ì?c khỏe rằng con quyÌ? viÌ£ coÌ? kêÌ?t quả xeÌ?t nghiệm vi ruÌ?t Zika duÌ›oÌ›ng tiÌ?nh, coÌ? nghĩa laÌ€ con quyÌ? viÌ£ Ä‘ã biÌ£ nhiễm vi ruÌ?t Zika. Trong tuần đầu nhiễm bệnh, vi ruÌ?t Zika ở trong maÌ?u người bệnh. Bảo vệ con quyÌ? viÌ£ traÌ?nh khoÌ‚ng biÌ£ muỗi đôÌ?t. Khi vi ruÌ?t vẫn coÌ€n trong maÌ?u của con quyÌ? viÌ£, trẻ coÌ? thể biÌ£ muỗi đôÌ?t, con muỗi Ä‘oÌ? coÌ? thể biÌ£ nhiễm vi ruÌ?t Zika vaÌ€ laÌ‚y truyền vi ruÌ?t sang người khaÌ?c.CS264360-Atestresults-children-fs-vie.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:43998
2017-02-14T20:01:07Z
å®¶é•·é ˆçŸ¥:我å°?å©çš„茲å?¡æª¢é©—呈陽性 : 是代表什麼æ„?æ€??For parents: a positive Zika virus test : what does it mean for my child? [Chinese]chi2 numbered pagescdc:43998http://stacks.cdc.gov/view/cdc/43998/ChildrenParentsZika Virus Infection/diagnosis2016å¹´3月14æ—¥For parents: a positive Zika virus test : what does it mean for my child? [Chinese]您剛從您的å°?兒科醫生或醫è·äººå“¡è™•å¾—知您å°?å©çš„茲å?¡æª¢é©—呈陽性,å?³è¡¨ç¤ºæ‚¨ çš„å°?å©å·²ç¶“感染到茲å?¡ç—…毒。在感染的第一個星期,茲å?¡ç—…毒會å˜åœ¨äººé«”çš„è¡€ 液ä¸ã€‚é ?防您的å°?å©å…?é?蚊å?å?®å’¬ã€‚當您å°?å©çš„血液ä¸å·²ç¶“å˜åœ¨ç—…毒時,蚊å? å?®å’¬åˆ°æ‚¨å°?å©å°±æœƒæ„ŸæŸ“到茲å?¡ç—…毒,並且將病毒傳æ’給他人。CS264360-Achinese/testresult-children-fs_zho-tw.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44000
2017-02-14T20:01:26Z
Para padres : Resultado positivo en la prueba de deteccioÌ?n del virus del Zika ¿QueÌ? implica esto para mi hijo?For parents: a positive Zika virus test : what does it mean for my child? [Spanish]spa2 numbered pagescdc:44000http://stacks.cdc.gov/view/cdc/44000/ChildrenParentsZika Virus Infection/diagnosis1 de junio del 2016For parents: a positive Zika virus test : what does it mean for my child? [Spanish]Acaba de enterarse por su pediatra o proveedor de atencioÌ?n meÌ?dica que el resultado de la prueba de deteccioÌ?n del virus del Zika de su hijo es positivo, lo que significa que su hijo tiene el virus del Zika. Durante la primera semana de la infeccioÌ?n el virus del Zika estaÌ? presente en la sangre de una persona. Evite que a su hijo lo piquen los mosquitos. Mientras el virus esteÌ? en la sangre de su hijo, si un mosquito lo pica puede infectarse con el virus del Zika y diseminarlo a otras personas.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44001
2017-02-14T20:01:32Z
Pour les parents : un reÌ?sultat positif au test de deÌ?pistage du virus Zika : Qu'est ce que cela signifie pour mon enfant ?For parents: a positive Zika virus test : what does it mean for my child? [French]fre2 numbered pagescdc:44001http://stacks.cdc.gov/view/cdc/44001/ChildrenParentsZika Virus Infection/diagnosis1er juin 2016For parents: a positive Zika virus test : what does it mean for my child? [French]Vous venez d'apprendre par votre peÌ?diatre ou par un prestataire de santeÌ? que votre enfant preÌ?sente un reÌ?sultat positif au test de deÌ?pistage du virus Zika, ce qui signifie que votre enfant est atteint d'une infection par le virus Zika. Pendant les premieÌ€res semaines qui suivent l'infection, le virus Zika est preÌ?sent dans le sang de la personne. ProteÌ?gez votre enfant contre les piquÌ‚res de moustiques. Lorsque le virus est preÌ?sent dans le sang de votre enfant, un moustique peut piquer votre enfant, se trouver infecteÌ? par le virus Zika et transmettre le virus aÌ€ d'autres personnes.CS266324-Atestresults_children_fs_fre-fr.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44002
2017-02-14T20:01:35Z
Fact sheet for patients : Interpreting Trioplex Real-time RT-PCR Assay (Trioplex rRT-PCR) resultseng3 unnumbered pagescdc:44002http://stacks.cdc.gov/view/cdc/44002/Molecular Diagnostic TechniquesReverse Transcriptase Polymerase Chain ReactionZika Virus Infection/diagnosisYou are being given this Fact Sheet because your blood, urine, cerebrospinal fluid (CSF), or amniotic fluid was tested for evidence of Zika virus infection. This testing was done because your healthcare provider believes you may have been exposed to Zika virus. The test used on your sample(s) is called the Trioplex Real-Time RT-PCR Assay (Trioplex rRT-PCR), which is a laboratory test designed to help detect Zika virus infection in humans.This Fact Sheet contains information to help you understand the risks and benefits of using the Trioplex rRT-PCR for Zika virus testing. You may want to discuss with your healthcare provider the benefits and risks described in this Fact Sheet and any additional questions you may have.trioplex-rt-pcr-factsheet-for-patients.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44003
2017-02-14T20:01:39Z
Fact sheet for healthcare providers : Interpreting Trioplex Real-time RT-PCR Assay (Trioplex rRT-PCR) resultseng5 unnumbered pagescdc:44003http://stacks.cdc.gov/view/cdc/44003/Molecular Diagnostic TechniquesReverse Transcriptase Polymerase Chain ReactionZika Virus Infection/diagnosisThe US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to authorize the use of the Centers for Disease Control and Prevention (CDC) Trioplex Real-time RT-PCR Assay (Trioplex rRT-PCR) for the in vitro qualitative detection of Zika virus with specified instruments. This assay tests for Zika virus, dengue virus and chikungunya virus RNA in serum, as well as whole blood and cerebrospinal fluid (CSF) (each collected alongside a patient-matched serum specimen). The assay also tests for Zika virus in urine, and amniotic fluid specimens (each collected alongside a patient-matched serum specimen). Testing should be conducted on specimens from people who meet CDC Zika clinical and/or epidemiologic criteria for testing and be performed in laboratories designated by the CDC; see www.cdc.gov/zika/hc-providers/index.html. This test is should be performed according to CDC’s algorithm for Zika testing (see http://www.cdc.gov/zika/laboratories/lab-guidance.html).The information in this Fact Sheet is to inform you of the significant known and potential risks and benefits of the emergency use of the Trioplex rRT-PCR (see www.fda.gov/MedicalDevices/Safety/EmergencySituations/ucm161496.htm).fact-sheet-for-hcp-eua-trioplex-rt-pcr-zika.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:44004
2017-02-14T20:01:47Z
Talk with your teen about e-cigarettes : a tip sheet for parentseng4 unnumbered pagescdc:44004http://stacks.cdc.gov/view/cdc/44004/Electronic CigarettesSmoking/adverse effectsElectronic Cigarettes/adverse effectsParent-Child RelationsParentsYoung AdultAdolescentPublication date from document properties.SGR_ECig_ParentTipSheet_508.pdfUnited StatesUnited States. Public Health Service. Office of the Surgeon General.National Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health.
oai:cdc.stacks:cdc:43970
2017-02-14T20:04:16Z
Registro de gravidez com zika nos EUA : o que os pais precisam saberUS Zika Pregnancy Registry : what parents need to know [Portuguese]por1 postercdc:43970http://stacks.cdc.gov/view/cdc/43970/PregnancyPregnancy ComplicationsRegistriesSex BehaviorSexually Transmitted Diseases, ViralZika Virus Infection22 de junho de 2016US Zika Pregnancy Registry : what parents need to know [Portuguese]O CDC criou o registro de gravidez com zika nos EUA para:• Saber mais sobre os riscos de infecção pelo zika vÃrus durante a gravidez.• Saber mais sobre o crescimento e desenvolvimento de bebês cujas mães tiveram zika durante a gravidez.Para o registro, o CDC coletará informações de saúde sobre o zika entre mulheres grávidas e seus bebês em todo o território dos Estados Unidos. O CDC, departamentos de saúde, médicos e profissionais de saúde usarão as informações deste registro para ajudar mulheres grávidas, seus filhos e famÃlias afetadas pelo zika.CS265172-AQual é a finalidade do registro? -- Quem está sendo incluÃdo no registro? -- O que será feito com as informações coletadas? -- O que devo fazer para ser incluÃda no registro? -- Quanto isso custa? -- E se eu tiver dúvidas?Centers Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:43971
2017-02-14T20:04:19Z
Overview of influenza surveillance in the United Stateseng5 numbered pagescdc:43971http://stacks.cdc.gov/view/cdc/43971/Influenza, Human/epidemiologyPublic Health SurveillanceThe Epidemiology and Prevention Branch in the Influenza Division at CDC collects, compiles and analyzes information on influenza activity year-round in the United States and produces FluView, a weekly influenza surveillance report, and FluView Interactive, which allows for more in-depth exploration of influenza surveillance data. The U.S. influenza surveillance system is a collaborative effort between CDC and its many partners in state, local, and territorial health departments, public health and clinical laboratories, vital statistics offices, healthcare providers, clinics, and emergency departments. Information in five categories is collected from eight different data sources that allows CDC to:• Find out when and where influenza activity is occurring• Track influenza-related illness• Determine what influenza viruses are circulating• Detect changes in influenza viruses• Measure the impact influenza is having on hospitalizations and deathsUnited StatesNational Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.
oai:cdc.stacks:cdc:43972
2017-02-14T20:04:27Z
Registro de Casos de Zika en el Embarazo en los EE. UU. : qué deben saber los padresUS Zika Pregnancy Registry : what parents need to know [Spanish]spa1 postercdc:43972http://stacks.cdc.gov/view/cdc/43972/PregnancyPregnancy ComplicationsRegistriesSex BehaviorSexually Transmitted Diseases, ViralZika Virus Infection22 de junio del 2016US Zika Pregnancy Registry : what parents need to know [Spanish]Los CDC diseñaron el Registro de Casos de Zika en el Embarazo en los EE. UU. con el fin de:• Obtener más información sobre los efectos de la infección por el virus del Zika (zika) durante el embarazo.• Obtener más información sobre el crecimiento y desarrollo de los bebés cuyas madres padecieron el zika durante el embarazo.Los CDC recopilarán, para el registro, información de salud sobre el zika en mujeres embarazadas y bebés en los Estados Unidos. Los CDC, departamentos de salud, médicos y proveedores de atención médica utilizarán la información del registro para ayudar a mujeres embarazadas, niños y familias que se han visto afectados por el zika.¿Cuál es el propósito del registro? -- ¿A quién se incluye en el Registro? -- ¿Qué se hará con la información obtenida? -- ¿Qué debo hacer para formar parte del registro? -- ¿Cuánto cuesta? -- ¿Qué pasa si tengo preguntas?Centers Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:43974
2017-02-14T20:04:35Z
Camp Lejeune, North Carolinaeng5 numbered pagescdc:43974http://stacks.cdc.gov/view/cdc/43974/Drinking WaterEnvironmental ExposureGroundwaterMilitary FacilitiesMilitary PersonnelRisk AssessmentWater Pollutants, ChemicalWater PollutionWater SupplyFact sheet for: Public health assessment for Camp Lejeune drinking water : U.S. Marine Corps Base Camp Lejeune, North Carolina. 2017.The Agency for Toxic Substances and Disease Registry (ATSDR), a federal public health agency, has completed the public health assessment (PHA) of drinking water at U.S. Marine Corps Base Camp Lejeune.This drinking water public health assessment (PHA):• Evaluates whether past volatile organic compound (VOC) exposures to chemicals at Camp Lejeune were likely to result in exposure-related disease.• Assesses additional VOC exposure scenarios requested by the Camp Lejeune Community Assistance Panel (CAP).• Evaluates more recent exposure to lead in drinking water at Camp Lejeune (2005–2013).Updated Jan. 2017CS265865CampLeJeune_Water_Factsheet_508.pdfCamp Lejeune (N.C.)North CarolinaUnited States. Agency for Toxic Substances and Disease Registry. Division of Community Health Investigations.
oai:cdc.stacks:cdc:43975
2017-02-14T20:04:41Z
Zika virus : a primer [for nurses]eng52 unnumbered slidescdc:43975http://stacks.cdc.gov/view/cdc/43975/Pregnancy ComplicationsPregnant WomenZika Virus InfectionCDC developed slides and a facilitation guide about Zika virus for nurses that can be used for grand rounds and other presentations. This presentation covers the following topics• Epidemiology, clinical manifestation, and clinical presentation of Zika• CDC guidance on pregnancy planning and contraception• CDC guidance on diagnosing and testing for Zika• Protecting pregnant women, infants, and children from Zika• Preventing transmission of Zika virus in healthcare settingsZika Grand Rounds Facilitation Guide: Nurseszikagrandrounds_nursing.pdfCenters for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:43960
2017-02-14T20:05:07Z
Enhanced STD Surveillance Network (eSSuN) : protocol and project implementation guideEnhanced SSuN Cycle 3 (Version 8.2)eng105 numbered pagescdc:43960http://stacks.cdc.gov/view/cdc/43960/Epidemiological MonitoringPublic Health SurveillanceSexually Transmitted Diseases/epidemiologyEnhanced SSuN Cycle 3 (Version 8.2)The STD Surveillance Network (SSuN) was established in 2005 (Cycle 1) to create an ongoing network of collaborating health departments with the capacity to implement a wide variety of surveillance activities, the flexibility to modify activities over time as trends dictated, and the ability to use surveillance data to guide programmatic action.SSuN Cycle 2 (2008 – 2013) expanded the network to include a greater number of collaborating health departments and further strengthened the human capacity and IT infrastructure. Activities in Cycle II included monitoring the prevalence of STDs, HIV, viral hepatitis, and risk behaviors in MSM, assessing trends in the burden of genital wart disease in patients attending STD clinics, monitoring HIV testing coverage in patients attending STD clinics, and implementing population-based enhanced gonorrhea surveillance.The current cycle (Cycle III, SSuN 2013 - 2018) continues to address these issues through enhanced and sentinel STD surveillance activities in specific populations (population component) and in expanded healthcare facilities (STD Clinics and Family Planning/Reproductive Health settings) serving populations at risk for STDs. These activities constitute Part A of SSuN and are the core activities of the network; this document outlines protocols and methods for implementing these enhanced and sentinel surveillance activities.ssun/protocol_v8.2_508.pdfUnited StatesNational Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention.
oai:cdc.stacks:cdc:43961
2017-02-14T20:05:11Z
Healthy aging at a glance, 2015 : helping people to live long and productive lives and enjoy a good quality of lifeeng5 numbered pagescdc:43961http://stacks.cdc.gov/view/cdc/43961/AgedHealth PromotionHealth Services for the AgedHealth Services ResearchPreventive Health ServicesPublic HealthToday, 45 million adults living in the United States—14% of the population—are 65 or older. By 2050, that number is expected to climb to about 80 million, or 20% of the population. This growth in the number and proportion of older adults is unprecedented. Americans are living longer than ever before. The Centers for Disease Control and Prevention (CDC) is at the forefront of the nation’s efforts to prevent and control chronic diseases so that these added years translate into quality years.CS257849Publication date from document properties.healthyaging-aag.pdfUnited StatesNational Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Adult and Community Health.
oai:cdc.stacks:cdc:43964
2017-02-14T20:05:28Z
Updated CDC Zika laboratory testing guidanceengcdc:43964http://stacks.cdc.gov/view/cdc/43964/Real-Time Polymerase Chain ReactionZika Virus Infection/diagnosisClinician Outreach and Communication Activity (COCA) conference call Thursday, December 1, 2016.CDC and several state and local health departments are testing for Zika virus. Every day, CDC learns more about Zika. CDC has recently released revised Zika virus laboratory testing guidance. During this COCA Call, clinicians will learn about the updated recommendations in CDC’s Guidance for U.S. Laboratories Testing for Zika Virus Infection and understand their role in testing specimens collected from patients. In addition, subject matter experts from CDC, the American Society for Microbiology, and the Association of Public Health Laboratories will discuss changes to the CDC Trioplex Real-time RT-PCR (rRT-PCR) Assay Emergency Use Authorization, examine the use of non-CDC developed assays, and review recommendations for plaque reduction neutralization testing in Puerto Rico.Objectives:• Describe all available Food and Drug Administration Emergency Use Authorizations for Zika virus assays.• Discuss Zika virus testing methods, including molecular and antibody detection.• Explain the role of public health laboratories, clinicians, and health departments in Zika testing and diagnosis.https://www.emergency.cdc.gov/coca/transcripts/2016/call-transcript-120116.aspGuidance for US Laboratories Testing for Zika Virus Infection / Christy Ottendorfer -- Diagnostic Testing for Zika Virus in Clinical Laboratories / Matthew J. Binnicker -- All Hands Response for Zika Testing / Grace Kubin.Puerto RicoUnited StatesKubin, GraceBinnicker, Matthew J.Ottendorfer, Christy L.Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of Emergency Operations.American Society for Microbiology.Association of Public Health Laboratories (U.S.)
oai:cdc.stacks:cdc:43940
2017-02-14T20:05:44Z
CDC Health Information Innovation Consortium 2015 annual reportCHIICeng12 numbered pagescdc:43940http://stacks.cdc.gov/view/cdc/43940/Information SystemsPublic Health InformaticsThis report highlights the overall impact CHIIC’s funding has had in advancing innovation within the agency and in partnership with key stakeholders. The report identifies the number of project proposals submitted in the 2015 project portfolio, the number of awarded projects, and highlights the purpose, results, and reuse or extension opportunities of the completed projects from the 2014 project portfolio.2015-chiic-annual-report_final.pdfCenters for Disease Control and Prevention (U.S.). Office of Public Health Scientific Services.CDC Health Information Innovation Consortium.
oai:cdc.stacks:cdc:43941
2017-02-14T20:05:56Z
South Carolina cancer control plan 2011-2015eng92 numbered pagescdc:43941http://stacks.cdc.gov/view/cdc/43941/Comprehensive Health CareHealth Promotion/methodsNeoplasms/prevention & controlPreventive Health ServicesProgram EvaluationPublic Health PracticeMore than 100 individuals worked together to create the South Carolina Comprehensive Cancer Control Plan (Cancer Plan), a plan of action that will allow South Carolinians to share ideas and resources to reduce the burden of cancer in each community. The Cancer Plan is a tool that can be used to identify gaps and successes in our efforts, to develop education and training resources, to advocate for new and better programs and policies and to provide a method for coordinating and communicating about cancer efforts statewide. The Cancer Plan is a catalyst for community action: our health advocates across the state work together to enact policies, laws and regulations that will decrease exposure to tobacco products, increase opportunities for healthy diet and exercise, and increase cancer screening, treatment and support.Funding for this Cancer Plan was provided by the Centers for Disease Control and Prevention (CDC) and the South Carolina Department of Health and Environmental Control (DHEC).Publication date from document properties.south_carolina_ccc_plan_2011_2015.pdfSouth CarolinaSouth Carolina Cancer Alliance.South Carolina. Department of Health and Environmental Control.Centers for Disease Control and Prevention (U.S.)
oai:cdc.stacks:cdc:43942
2017-02-14T20:05:59Z
Northern Plains American Indian Comprehensive cancer plan : a revision for years 2013-2017eng38 numbered pagescdc:43942http://stacks.cdc.gov/view/cdc/43942/Comprehensive Health CareHealth Promotion/methodsIndians, North AmericanNeoplasms/prevention & controlPreventive Health ServicesProgram EvaluationPublic Health PracticeCancer continues to be a concern for the Northern Plains American Indian (NPAI) population. Although great strides have been made in education and awareness, early prevention and detection, culturally relevant approaches, and survivorship. NPAI communities continue to suffer from some of the highest rates of cancer and cancer deaths compared to both other Native and non-Native populations. With continuing support from the U.S. Centers for Disease Control and Prevention (CDC) and the Great Plains Tribal Chairmen’s Health Board (GPTCHB) the Northern Plains Comprehensive Cancer Control Program has joined with partners from Great Plains tribes, tribal leadership, Indian Health Services, states, universities, and many other cancer control stakeholders to continue working together towards a common goal of strengthening collaborative efforts to prevent cancers and increase access to quality cancer care services from diagnosis through survivorship or end of life.A Project of the Northern Plains Cancer Coalition.Support provided by the Centers for Disease Control and Prevention (CDC Grant #U55-CCU824797) to make this plan possible.Publication date from document properties.northern_plains_ccc_plan.pdfU55-CCU824797Great Plains Tribal Chairmen’s Health Board.Northern Plains Cancer Coalition.Centers for Disease Control and Prevention (U.S.)
24ebffc355a444679832739319c14d6f